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Mastitis is the most common and economically damaging production disease of dairy 
cows. In the majority of cases it is induced by intramammary infection with a pathogen. 
Identification of mastitis-causing pathogens enables treatments to be targeted appropriately, 
avoiding unnecessary antimicrobial treatments, and enabling design of the best possible 
herd level management protocols. Diagnosis of bovine IMI has been traditionally based on 
microbial culture of aseptically taken quarter milk samples. Due to the requirements of 
modern dairy production and development of molecular technologies, milk samples can be 
examined for target pathogens with DNA-based methods such as multiplex real-time PCR 
assays. Despite several years of routine use of PCR assays in some countries, scientific 
knowledge concerning interpretation of the results is sparse.  
 
This dissertation focuses on providing new information for diagnosing bovine mastitis 
using multiplex real-time PCR. In order to accomplish that, first a commercial multiplex 
real-time PCR assay was compared with the current reference method, conventional culture 
(I). It showed that PCR was a reliable diagnostic method for Staphylococcus aureus, but 
less reliable for diagnosing true non-aureus staphylococci infections. In an experimental 
challenge study (IV), elimination of Staphylococcus epidermidis and S. simulans was 
followed with PCR in addition to conventional culture. The results showed that PCR yielded 
target-positive results for several days after the culture results were negative. Subsequently, 
the time of sampling related to the onset of inflammation may be of importance when 
interpreting the PCR results.  
 
Secondly, quarters with suspected mastitis were sampled using two experimental 
techniques, in addition to the conventional aseptic technique (II, III), and examined with 
multiplex real-time PCR. In the needle technique, the whole teat and teat area were 
bypassed. With the cannula technique, the teat orifice and the teat canal were bypassed. The 
results showed that samples taken with alternative techniques were of better hygienic 
quality. We also reported that over half of the non-aureus staphylococci findings in our PCR 
results originated from sites other than the mammary gland.  
 
A diagnosis of a true IMI or mastitis, with possible outcome of an antimicrobial 
treatment course for the animal, cannot be based solely on a PCR result, but must be 
combined with all the available information about a cow`s history, symptoms, changes in 
milk and indicators of inflammation. Some microbes detected with PCR can be considered 
to be contaminants, especially when present with low levels of DNA. If the signs of the cow 
or the degree of udder inflammation do not fit the usual signs caused by the pathogen 
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Mastitis is defined as an inflammation of the parenchyma of the mammary gland (Zhao 
and Lacasse, 2008), a local protective reaction against irritation (International Dairy 
Federation, 2011) of any possible cause. The most common cause of mastitis is 
intramammary infection (IMI), defined as the presence of pathogenic micro-organisms in 
the secretory tissue and the duct and tubules of the bovine mammary gland (International 
Dairy Federation, 2011).  
 
Mastitis decreases the ability of the mammary gland to produce milk. Concentrations of 
milk components, such as fat and protein, decrease and proteolytic activity increases, 
leading to poor milk quality (Seegers et al., 2003). Mastitis causes pain and discomfort to 
affected cows (Fogsgaard et al., 2012; Sepúlveda-Varas et al., 2014; Fogsgaard et al., 2015). 
In addition, mastitis is one of the major reasons for antimicrobial use in dairy cattle (Erskine 
et al., 2003; Halasa et al., 2007; Barlow, 2011). Prevalence of bovine mastitis varies across 
countries between 19 – 53% (Pitkälä et al., 2004; Østerås et al., 2006; Haltia et al., 2006; 
Hiitiö et al., 2017) and is still the most common disease among dairy cows. Production 
losses, discarded milk, treatment costs, increased labour, premature culling and replacement 
costs (Halasa et al., 2007; Heikkilä et al., 2012) also make mastitis the most economically 
damaging production disease of dairy cows (Seegers et al., 2003).  
 
Mastitis-causing pathogens may originate from the environment, milking equipment, 
barn environment, udder, or skin of the cow or humans. Udder pathogens may in some herds 
be of a more contagious nature, and in some herds environmental, requiring different 
approaches for herd mastitis control. IMI is the consequence of a failure of the first line 
defence mechanisms, i.e. mechanical barriers of the teat. If the subsequent cellular and 
humoral defence mechanisms also fail, mastitis is induced (Zhao and Lacasse, 2008). 
Mastitis can be clinical or subclinical. In clinical mastitis, pathological changes to the 
glandular tissue cause the typical inflammatory signs: swelling, heat, pain, redness and loss 
of function (Radostits et al., 2007). The alveoli and the mammary gland lose their structure 
and the blood-milk barrier is disrupted (Zhao and Lacasse, 2008), leading to visible changes 
in the milk, such as discoloration and clots or flakes. Mastitis can sometimes even be fatal. 
During IMI and mastitis, the number of polymorphonuclear leucocytes, comprising the 
majority of the somatic cells in the milk, increases dramatically. The primary change in 
subclinical mastitis is elevated milk somatic cell count (SCC), which can be observed with 
several cow-side and automatic detection methods.  
 
Different microbes harbour different virulence factors and induce mastitis with different 
degrees of severity of tissue damage and different prognoses (Zhao and Lacasse, 2008; 
Schukken et al., 2011). Susceptibility to antimicrobials and treatment response also differ 
among bacterial species. Traditionally, mastitis-causing pathogens have been divided into 
major and minor pathogens according to the severity of the caused disease, degree of 
economic loss or infectious features they possess. The most important major pathogens 






Østerås et al., 2006; Bradley et al., 2007; Persson Waller et al., 2009; Vakkamäki et al., 
2017). The proportion of minor pathogens, especially of non-aureus staphylococci, has 
continuously increased (Pitkälä et al., 2004; Vakkamäki et al., 2017), currently representing 
the most prevalent mastitis-causing organisms in subclinical mastitis and IMI in many 
countries, for example in Finland, the Netherlands and Germany (Sampimon et al., 2009; 
Tenhagen et al., 2006; Taponen and Pyörälä, 2009; Vakkamäki et al., 2017). Different 
factors predispose dairy cows to mastitis, including management, stall type, milking system, 
breed, herd characteristics and season (Østerås et al., 2006; Lievaart et al., 2007; Hiitiö et 
al., 2017; Taponen et al., 2017). 
 
Identification of the mastitis-causing pathogens enables one to target the treatments 
appropriately, to avoid unnecessary antimicrobial treatments, and to create the best possible 
herd level management protocols. Diagnosis of IMI is based on microbial culture of 
aseptically taken quarter-milk samples (International Dairy Federation, 2011). Cow 
composite (Reyher and Dohoo, 2011) and bulk tank milk samples (Fox et al., 2005; Rysanek 
et al., 2009; Barkema et al., 2009) have also been used in mastitis diagnostics, mainly in 
eradication and surveillance programmes. Conventional culture has been, and still is, the 
reference (gold standard) method to identify the microbiological cause of IMI (Griffin et 
al., 1977; Middleton et al., 2017). 
 
The modern dairy industry has elicited a need for more accurate and faster methods to 
diagnose bovine IMI. DNA-based molecular diagnostic assays, for example different 
variations of the Polymerase Chain Reaction (PCR), including conventional, real-time and 
multiplex real-time PCR, have been introduced in bovine mastitis diagnostics since the 
beginning of the 21st century. Advantages of DNA-based methods are greater objectivity, 
increased speed and higher sensitivity (Gillespie and Oliver, 2005; Taponen et al., 2009; 
Koskinen et al., 2009). The ability to detect DNA also from dead and growth-inhibited 
pathogens may also be considered an advantage in some contexts (Taponen et al., 2009; 
Bexiga et al., 2011a). Finland was the first country to adopt PCR for routine mastitis 
diagnostics. Currently, over 80% of all milk samples in Finland are tested only with 
commercial multiplex real-time PCR assay instead of culture. The method was taken into 
use relatively quickly by the dairy industry, but it seems to work well in routine use 
(Vakkamäki et al., 2017). The interpretation of the results has been challenging in the 
absence of agreed guidelines and lack of comprehensive scientific knowledge. This has been 
especially true when results have included several different target species.  
 
This dissertation is comprised of a review of bovine mastitis diagnostics, focusing on 
PCR diagnostics, and four independent studies where multiplex real-time PCR was used in 







2 Review of the literature 
2.1 Background in diagnosing bovine intramammary infection 
(IMI) 
Mastitis is one of the major reasons to use antimicrobials in dairy cows (Pol and Ruegg, 
2007). Historically, the goal of treatment of mastitis has not necessarily been bacterial cure, 
but normalization of the milk, to continue delivery of milk of the mastitic cow to the dairy 
as soon as possible (Barlow, 2011). In countries where veterinary consultation in treatment 
of mastitis is not obligatory, routine treatment with broad spectrum antimicrobials has been 
the rule (Barlow, 2011; Oliver and Murinda, 2012; Cha et al., 2016). Use of antibiotics in 
dairy cows may contribute to an increase in antimicrobial resistance. With current concerns 
and evidence of the global spread of antimicrobial resistance (WHO, 2018) antimicrobial 
use should be justified and prudent.  
 
Only a minority of the clinical mastitis cases benefit from antimicrobial treatment, 
depending on the causative agent (Oliveira and Ruegg, 2014; Ruegg, 2014). Knowledge of 
the causative agent provides a basis to avoid unnecessary antimicrobial treatments and 
expensive withdrawal times. With pathogens, where antimicrobial intervention is relevant 
(Pyörälä, 2009), the treatment can be targeted accordingly with the most suitable narrow-
spectrum antimicrobials and adequate length of the course. The on-farm data, consisting of 
aseptically taken quarter milk samples over a longer period, serve as the basis for the 
mastitis management and udder health protocols on each farm.  
 
An aseptic milk sample from the mastitic quarter can be submitted for microbiological 
analysis to diagnose the causal pathogen. In Nordic countries, sampling of quarters with 
suspected mastitis has been successfully advised for decades (Hiitiö et al., 2017; Vakkamäki 
et al., 2017). Unfortunately, routine identification of mastitis-causing pathogens from the 
infected quarter elsewhere has been rare (Ruegg, 2014; Cha et al., 2016). 
 
The first level of identification with culture-based methods is the division of microbes 
according to Gram-staining, into Gram-negatives or Gram-positives. This is possible even 
on dairy farms using on-farm culture methods (Lago et al., 2011; Ruegg, 2014; Cha et al., 
2016). This level of identification can be used in deciding whether to treat or not to treat 
clinical mastitis. It has been estimated that 50 – 80% of Gram-negative mastitis cases do not 
require antimicrobial treatments due to high levels of antimicrobial resistance and 
spontaneous cure rates (Roberson, 2003; Suojala, 2010; Schukken et al., 2011). 
Spontaneous cure rates and antimicrobial resistance differ also among Gram-positive 
pathogens (Barlow, 2011). The ideal protocol is to send a milk sample to a laboratory, where 
the microbe can be identified at a species or a group of species level and antimicrobial 
susceptibility can be tested if deemed necessary (Middleton et al., 2017). This level of 
identification increases the immediate diagnostic costs, but can provide valuable 






al., 2016). Due to the logistic challenges with milk samples and the culture process itself, 
obtaining the results may take several days (Cha et al., 2016). A long response time delays 
the start of the treatment and may affect the outcome and further spread of some pathogens, 
for example S. aureus (Barkema et al., 2006; Cha et al., 2016). 
2.2. Indicators of inflammation 
Milk quality can be evaluated, and suspected mastitis cases confirmed by measuring 
different indicators of inflammation from milk. 
2.2.1. Somatic cell count (SCC) 
 
SCC is the most used and studied indicator of inflammation in milk. In normal milk of 
a healthy quarter, SCC is clearly under 100 000 cells/ml (Pyörälä, 2003; Schukken et al., 
2003), with the cell population comprising mostly macrophages (Rainard and Riollet, 2006). 
Variation in SCC is caused by stage of lactation, milking, parity, breed and stress in non-
infected quarters (Schukken et al., 2003; Bradley and Green, 2005; Olde Riekerink et al., 
2007), but inflammation of the mammary quarter results in definite increase of SCC. SCC 
increases because of an excessive recruitment of neutrophils to the inflamed tissue and milk 
(Rainard and Riollet, 2006). Some pathogens elicit a greater SCC response than others 
(Djabri et al., 2002; Simojoki et al., 2011; Schukken et al., 2011). SCC over 200 000 cells/ml 
indicates a high probability of mastitis (Schepers, 1997; Schukken et al., 2003). In cases 
where the immune system fails to remove the microbe, a chronic infection follows, 
maintaining high SCC for a longer period (Schukken et al., 2003). SCC levels can be 
measured and monitored at quarter-, cow- and herd-level (Schukken et al., 2003). 
 
The California Mastitis Test (CMT) is the most common cow-side method for detecting 
quarters with increased milk SCC. An advantage of this simple test is that inter-quarter 
comparison is automatically incorporated into the test, which facilitates the interpretation. 
In the CMT test, 3 ml of milk and 3 ml of CMT reagent are mixed on a test plate. The test 
reagent reacts with DNA: the more DNA (from somatic cells) the milk sample contains, the 
greater the viscosity on the test plate (International Dairy Federation, 2013). Invariably a 
scoring system on a scale of 1 – 5 is used, where 5 indicates SCC over 5 000 000 cells/ml 
of milk (International Dairy Federation, 2013). Despite CMT being highly subjective, rough 
estimates of the SCC can be generated and its value in practice is high (Sargeant et al., 
2001). Several automatic methods are available for determination of SCC, such as electro-
optical and fluoro-optical devices (Pyörälä, 2003). Automatic milk systems use their own 
methods for monitoring SCC, such as the Online Cell Counter (OCC, DeLaval, Sweden) 






2.2.2. Other indicators 
Other less frequently used indicators of mastitis are also available, including N-acetyl-
b-D-glucosaminidase, milk amyloid-A and lactate dehydrogenase (Pyörälä, 2003). The 
amount of lyzozomal enzymes originating from phagocytes or epithelial cells, such as N-
acetyl-b-D-glucosaminidase (NAGase), increases during inflammation (Kitchen et al., 
1980), reflecting the destruction of mammary tissue. In subclinical mastitis, the overall 
performance of this kind of indicator has been reported to be inferior compared with SCC 
(Nyman et al., 2014; Nyman et al., 2016b) for measuring the actual inflammatory response. 
LDH and NAGase results are more affected by cow factors than SCC in IMI negative cows 
(Nyman et al., 2014). Concentration of NAGase activity is also associated with the amount 
of bacterial DNA in milk samples (Kalmus et al., 2013). 
 
NAGase activity in milk varies considerably, especially among healthy cows (Chagunda 
et al., 2006b). NAGase activity has been reported to be higher in clinical than in subclinical 
mastitis (Pyörälä, 2003; Chagunda et al., 2006b). Milk NAGase releases 4-
methylumbellipheron (4-MU) in an acidic environment, which fluoresces in an alkaline 
environment. NAGase activity is measured against a known 4-MU concentration and 
reported as picomoles of 4-MU/min per microliter of milk (Hovinen et al., 2016). The upper 
limit for normal milk is 1.04 pmol of 4-MU/min per microliter of milk and the upper 
quantification limit is 24.49 pmol of 4-MU/min per microliter of milk (Hovinen et al., 2016) 
Taponen et al. (2009) reported an average NAGase activity for clinical mastitic cases of 
18.7 pmol of 4-MU/min per microliter of milk (Taponen et al., 2009). Chagunda et al. 
(2006b) used another modification of the test, reporting a mean for clinical mastitis cases of 
69.42 micromoles min-1 l-1. NAGase has been reported to be a reliable indicator at least for 
some pathogens (Kalmus et al., 2013), but SCC still possesses the best overall ability to 
identify IMI over lactate dehydrogenase and NAGase (Nyman et al., 2016b).  
 
Electrical conductivity (EC) is the most commonly used method to detect mastitis on-
line and in automatic milking systems (AMS). It is based on the increase of Na+ and Cl- in 
mastitic milk, but it has been reported to be inadequate to detect subclinical or clinical 
mastitis (Hovinen et al., 2006). Changes in colour of milk may also be detected and this is 
a commonly used indicator of mastitic milk in visual inspection as well as in AMS detection 
devices. However, automatic diversion of milk, based on changes in colour or EC, has been 
reported to be unreliable (Hovinen and Pyörälä, 2011). Biological models to combine the 
information of different indicators of mastitis for AMS have been introduced (Chagunda et 






2.3. Microbiological diagnosis of bovine IMI 
2.3.1 Milk sampling 
2.3.1.1.  Aseptic quarter milk sampling  
Aseptic quarter-based milk sampling according to international standard methods 
(Middleton et al., 2017) is a prerequisite for a reliable microbiological result in mastitis 
diagnostics. The barn environment is a challenge for aseptic procedures. Complete asepsis 
cannot be achieved but all possible sources of contamination during sampling should be 
minimized. First, the udder should be brushed from possible loose dirt, hair and bedding 
material. Several streams of milk are milked on to a test plate and the milk is visually 
inspected. A pair of disposable gloves is put on. The teat end of the test quarter is cleaned 
with cotton moistened with 70% alcohol, at least three times or until visibly clean. The cap 
of the sterile milking tube should be protected, and the tube kept in a nearly horizontal 
position during sampling to avoid contamination from above. A few centimetres of milk in 
the bottom of the tube is enough for analysis. Tubes are marked with date and identification 
of the cow and quarter and stored in a refrigerator until culturing or with preservative tablets 
if studied with PCR assays.  
2.3.1.2. Cow composite sampling 
Cow composite samples include milk from all quarters of the cow combined in one test 
tube. The traditional purpose of composite samples is to determine content of certain milk 
solids and SCC at the cow-level for dairy herd improvement (DHI), but they might also be 
used to diagnose subclinical IMI with microbiological tests (Reyher and Dohoo, 2011). 
Composite samples are usually taken with automatic sampling devices during milking, 
without any disinfection of the teats. The possibility of environmental and skin 
contamination is high and samples are prone to carryover phenomena, e.g. microbial 
contamination from preceding cows due to the function of the sampling devices (Løvendahl 
and Bjerring, 2006; Mahmmod et al., 2013a; Mahmmod et al., 2014). Composite samples 
can also be collected following aseptic sampling techniques by collecting milk aseptically 
from each quarter into the same, single tube. With this method, some level of asepsis can 
be maintained.  
 
The diagnostic goal of cow composite samples is mainly to screen cows for specific 
pathogens. This kind of information may be used in eradication programs and surveillance 
of highly contagious pathogens like Mycoplasma (M.) bovis (Fox, 2012). Results from non-
aseptic samples have been used in cow level mastitis diagnostics (Cederlöf et al., 2012; 
Mahmmod et al., 2013b). Definition for true IMI based on these samples has been difficult 
because, for example, Streptococcus (Str.) agalactiae has been shown to be present in the 






colonizing the skin of the udder. A large Canadian study, where composite samples were 
cultured to diagnose subclinical IMI, concluded that sensitivity (Se) and specificity (Sp) of 
culture were at moderate levels, differed markedly among species and improved when more 
than one quarter of the cow was infected (Reyher and Dohoo, 2011).  
2.3.1.3. Bulk tank milk (BTM) sampling 
 
An indication for microbiological analysis of bulk tank milk is to evaluate milk quality 
and possibly udder health of the tested herd (Barkema et al., 2009; Rysanek et al., 2009; 
Katholm et al., 2012). It can be used in surveillance of certain udder pathogens like M. bovis 
and Str. agalactiae at herd-level (Fox et al., 2005; Barkema et al., 2009; Katholm et al., 
2012). Microbiological analysis of bulk tank can be done with culture or PCR assays with 
specific selection of target pathogens.  
2.3.1.4. Carryover in milk sampling 
 
Carryover is a phenomenon where the present milk sample includes residual milk from 
previous samples. In AMS, milk samples are collected with built-in meters. Residual milk 
from a previous cow may remain in the milking unit(s) and cause cross-contamination. 
Carryover has been reported to occur in parlour milking (Mahmmod et al., 2013a; 
Mahmmod et al., 2014; Mahmmod et al., 2017) and the sampling devices of automatic 
milking robots (Løvendahl et al., 2010; Da Silva et al., 2016). It may affect pregnancy-
associated glycoprotein (PAG) levels (Da Silva et al., 2016) milk solids like fat, SCC 
(Løvendahl et al., 2010) and mastitis pathogen results (Mahmmod et al., 2013a; Mahmmod 
et al., 2014; Mahmmod et al., 2017). Carryover is suspected also in bulk tank milk samples 
(Nielsen et al., 2015), where residues of milk may be present in taps of the bulk tanks and 
other sampling equipment.  
2.3.2. Conventional bacterial culture (BC) 
 
Bacterial culture (BC), carried out according to the internationally agreed standards 
(Middleton et al., 2017) is considered the reference method in mastitis diagnostics. BC is 
based on culturing a milk aliquot from an aseptically taken quarter milk sample on an agar 
plate and incubating the plate for 24 to 48 hours. Viable microbial cells can be detected as 
colony forming units (cfu). Representatives of morphologically different colonies, 
indicating different species, are identified according to standard microbiological schemes 
(Middleton et al., 2017). If the agar plate contains more than two different species, the 







One of the major advantages of BC is that only viable microbial cells are detected. 
Subsequently, it can be assumed that these viable microbes are also capable of inducing 
mastitis. No agreed standard for the detection limit of bovine intramammary infection (IMI) 
is available. Andersen et al. (2010) classified IMI in two separate definitions: 1) milk sample 
containing an organism of interest with ³ 1 000 cfu/ml on the test day or 2) the organism of 
interest isolated in three consecutive weekly samplings at least twice. Dohoo et al. (2011) 
concluded that a criterion for positive IMI when examining only a single milk sample could 
be a single colony from a 0.01 ml milk sample (resulting detection limit of 100 cfu/ml), with 
the exception of CNS, where 2 colonies per 0.01 ml of milk would be a more appropriate 
limit (Dohoo et al., 2011). In surveys around the world, definitions for positive IMI have 
varied and often been left unannounced. For example, Bradley et al. (2007) used the most 
common limit of 100 cfu/ml for positive IMI, Pitkälä et al. (2004) used 500 cfu/ml and 
Østerås et al. (2006) adjusted the detection limit according the pathogen. 
 
The definition of a gold standard is ‘a perfect reference test’. It can be argued that BC 
does not meet this requirement because several disadvantages of the method can be 
recognized. One of the most commonly acknowledged problems of BC is represented by 
milk samples without microbial growth. This is also true for clinical mastitis cases, where 
the milk is visibly changed and signs of inflammation may be seen in the affected udder and 
the cow, in addition to high SCC. In clinical mastitis cases, proportions of negative samples 
vary between 10 – 27% (Sargeant et al., 1998; Waage et al., 1999; Bradley et al., 2007; 
Koivula et al., 2007) and in subclinical cases the proportions are even higher (Bradley et al., 
2007; Koivula et al., 2007). Several different reasons for culture-negative samples have been 
proposed. The amount of pathogen in the milk sample may simply be too low, or the 
infection be of very short duration (Sears and McCarthy, 2003; Walker et al., 2011). 
Sensitivity of positive detection increases when inoculum size is increased, at least for S. 
aureus (Walker et al., 2010). In addition, bacteria are not homogenously distributed in 
samples. Due to the immune response against the invading microbe, mastitic milk contains 
several growth-inhibitory compounds that may inhibit bacterial growth on agar plates 
(Rainard and Riollet, 2006). The milk sample may also contain antimicrobial residues if it 
is collected too soon after antimicrobial treatment in an attempt to confirm bacteriological 
cure. 
 
BC is also time consuming: accurate identification of the causative pathogen is often 
only possible after 48 hours of incubation and further diagnostic tests. For some pathogens, 
like M. bovis, correct identification requires special media and incubation times up to 6 – 
10 days (Maunsell et al., 2011). In addition to international guidelines for mastitis 
diagnostics (Middleton et al., 2017), standards including the requirements for the laboratory, 
quality control and traceable results, are available. ISO 17025 is the main standard for 
laboratories producing testing and calibration results. Despite standardized procedures in 
BC, considerable variation in diagnostic procedures and interpretation of the results has 






2.3.2.1. On-farm culture systems 
Several on-farm tests for mastitis diagnostics have been introduced. On-farm culture 
systems are based on selective agar media or petrifilms. Milk samples are cultured on agars, 
promoting the growth of microbes possessing certain characteristics. Most common plates 
target differentiating between Gram-negative and Gram-positive microbes. The Di-Plate 
(Minnesota Easy Culture System II, University of Minnesota Laboratory for Udder Health, 
MN) system includes two media, one selective for Gram-negative microbes and one for 
Gram-positive, hindering the growth of Gram-negatives. A Tri-Plate system includes Gram-
negative selective agar (McConkey agar) and a medium for growth of catalase-negative 
Gram-positive cocci (most commonly streptococci) in addition to the conventional tryptic 
soy blood agar (Minnesota Easy Culture System, University of Minnesota Laboratory for 
Udder Health, MN). Viora et al. (2014) used a three-plate test kit (VetoRapid, Vétoquinol, 
Buckinghamshire, UK), where one-third of the plate is a selective agar for coliforms, one 
third a modified mannitol salt agar and one third is a modified Edwards agar (Viora et al., 
2014). 
 
Royster et al. (2013) compared the Di-Plate and Tri-Plate systems with conventional 
bacterial culture in identification of mastitis pathogens. They concluded that results from 
Di-Plate and Tri-Plate were most reliable when used only to diagnose three robust categories 
of Gram-negative, Gram-positive and no growth (Royster et al., 2014). Viora et al. (2014) 
reported that test reliability between tri-plate agar and conventional culture varied according 
to the causal pathogen. McCarron et al. (2009) compared the Di-Plate media with the 3M 
Petrifilm system in diagnosing clinical mastitis. 3M Petrifilm system included two films, 
one film selective for aerobic microbes and one for coliforms (McCarron et al., 2009). They 
concluded that both Bi-Plate and 3M Petrifilm systems performed well in categorizing 
isolates from clinical mastitis cases in two groups: Gram-positive and Gram-negative. 
Neither test could reliably determine contaminated samples (McCarron et al., 2009). 3M 
Petrifilm has been tested for even more robust characterization of bacterial growth or no 
bacterial growth for low SCC cows before dry-off (Cameron et al., 2013). Reasonable 
sensitivity (85.2%) for the 3M Petrifilm system was reported (Cameron et al., 2013). 
 
On-farm culture has been reported to have substantial benefits on those farms where 
clinical mastitis has been based on only empirical, sign-based treatments by the farmer 
(Lago et al., 2011). Benefits have been reported also if blanket dry cow therapy has been 
changed to selective dry cow therapy (Lago et al., 2011; Cameron et al., 2014). Lago et al. 
(2011) reported reduction of intramammary antibiotics by half after implementing an on-








2.3.3. Detection of pathogen DNA with polymerase chain reaction (PCR) 
and its variations 
 
According to Gillespie and Oliver (2005) one of the greatest single advantages of DNA-
based molecular methods is the focus on identification of actual nucleic acid compositions 
of the microbial genome instead of only the phenotypic expression of the products that those 
nucleic acids encode. Several different DNA-based molecular methods exist in modern 
microbiology (Tang, 2013) and more assays are constantly developed. The most common 
DNA-based molecular method to date in detecting pathogen DNA from pathogens involved 
with bovine IMI is the PCR and its variants.    
 
PCR is a very delicate in vitro molecular technology, where multiple copies of DNA 
segments of interest are generated within a few hours using polymerase enzymes. It has 
been widely used in detecting disease-causing organisms and has become a standard method 
in diagnostic microbiology (Tang, 2013). PCR was developed and introduced by Mullis et 
al. (1986). The components of a PCR reaction include purified and extracted target-DNA 
(e.g. the sample or template), polymerase enzyme, primers, deoxynucleotide triphosphates 
(dNTP) and buffer solution with optimized pH and concentrations of various substances 
including enzyme cofactor magnesium (Mullis et al., 1986). 
2.3.3.2. Polymerase enzyme 
 
Polymerase enzymes originate from thermophilic bacteria (Innis et al., 1990; Haki and 
Rakshit, 2003). These bacteria have adapted to extreme temperatures with adapted cell 
membranes, positive supercoils in their DNA and by producing thermostable proteins (Haki 
and Rakshit, 2003), among other characteristics. One of the first and most frequently used 
polymerase enzymes is Taq polymerase from the bacterium Thermus aquaticus (Haki and 
Rakshit, 2003). The purpose of the polymerase enzyme is to serve as the catalyst for the 
elongation phase (Innis et al., 1990) of the PCR cycle. The polymerase enzyme attaches 
dNTP according to the template base order.  
2.3.3.3. Primers 
 
Primers are synthetic oligonucleotide sequences, which precede the desired target DNA 
sequence. A pair of primers attach to each complementary strand of DNA marking the 
initiation points for amplification (Tang, 2013). Without a primer, the polymerase enzyme 
cannot work because it requires double-stranded DNA (Tang, 2013).  
 
Primers are relatively short (10 – 30 nucleotides) and of 50 – 60% guanine-cytosine 
(G+C) composition (Innis et al., 1990). Successful design of primers is a prerequisite for 






consequently the annealing temperature (Tang, 2013), depending on the number of 
hydrogen bonds. Various different softwares are available for primer design (Pereira et al., 
2008). Concentration of primers affects the accuracy of the PCR reaction: if primer 
concentration is too high, primers may attach to each other, making primer-dimers and 
consequently lowering the amount of detected target-DNA (Innis et al., 1990). 
2.3.3.4. PCR cycle 
 
The PCR cycle consists of three process steps: denaturation, annealing and extension. In 
denaturation, the coiled DNA strands are separated at a temperature of 90 – 95 °C (Mullis 
et al., 1986). If the denaturation temperature is too high, DNA may break and if it is too 
low, the hydrogen bonds between the strands do not open. The annealing phase is carried 
out at a lower, 55 – 75 °C, temperature, allowing the primers to anneal correctly. The 
temperature affects the accuracy and degree of attachment.  In the final extension phase, 
polymerase enzyme catalyses the synthesis of the target DNA copy from the dNTP. With 
this complementary base-pairing a new strand is formed (Mullis et al., 1986). 
 
The PCR cycles are induced in thermal cyclers, where temperatures and times of cycle 
steps can be more effectively maintained and changed, compared with the first versions in 
water baths (Innis et al., 1990). After the first three cycles, two copies of the target DNA 
and six fragments with variable lengths are produced. After 20 cycles the number of target 
DNA compared with the variable length fragments is over 1000-fold. When conditions are 
optimal, the number of target DNA strands is doubled with every cycle. The maximum 
number of cycles is 40.0. Cycles over 40.0 produce nonspecific background products of no 
value (Mullis et al., 1986; Innis et al., 1990) and with suboptimal reproducibility. 
2.3.3.5. Detection of PCR products 
 
DNA sequences must be identified after amplification. DNA is a negatively charged 
molecule (Nelson et al., 2005) with a natural tendency to move towards a positive pole when 
exposed to an electric current. In gel electrophoresis, DNA products are subjected to 
electrical current in an agarose matrix. Fragments line up according to their size as smaller 
products move faster than larger ones in the gel matrix. Visualization of the patterns is 
possible with ethidium bromide (Tang, 2013). Identification of species is done by 
comparing obtained patterns with reference patterns.  
2.3.3.6. Real-time PCR 
 
In real-time PCR, the PCR product can be detected during the amplification process 






labelled probes. These labelled primers are termed oligos (Klein, 2002). Fluorescence can 
be detected when the probe detaches or is hybridized (Klein, 2002). The amount of 
fluorescence increases in direct proportion with the target DNA (Tang, 2013). To date, the 
most used PCR chemistries are SYBR Green and TaqMan. With SYBR Green, the 
fluorescence is emitted when binding to the double-stranded DNA occurs and with TaqMan, 
fluorescence is emitted only when the correct product has been formed (Tang, 2013). 
Fluorescence is detected with automated optic devices. 
 
Measurement of fluorescence is carried out in every cycle, enabling quantitative features 
of real-time PCR (Pereira et al., 2008). Real-time PCR can be considered a semi-quantitative 
method because the number of products is not exact, but the result of an external standard 
curve (Pereira et al., 2008; Tang, 2013). The cycle threshold value (Ct) is the number of 
cycles needed to obtain a predetermined level of fluorescence. The greater the amount of 
target DNA in a sample, the earlier the detection threshold is achieved (Tang, 2013). 
Advantages of real-time PCR over conventional PCR are the higher precision and technical 
sensitivity (<5 microbial copies) (Klein, 2002) and lower turn-around times (Phuektes et al., 
2001; Klein, 2002; Pereira et al., 2008; Koskinen et al., 2009). Post PCR handling can be 
avoided, minimizing the risk of cross-contamination in the laboratory (Pereira et al., 2008). 
Edwards and Gibbs (1994) concluded that most real-time PCR assays showed high precision 
and reproducibility, but the accuracy of the data depended on sample preparation, quality of 
the standard and the chosen target gene (Edwards and Gibbs, 1994).  
2.3.3.7. Multiplex real-time PCR 
 
Multiplex real-time PCR reactions include oligos for several different targets. Primers 
for multiplex real-time PCR must be designed to be of unique sizes (Tang, 2013) and similar 
kinetics, otherwise they not able to function (Edwards and Gibbs, 1994; Tang, 2013). With 
each additional primer, the possibility of nonspecific products increases (Edwards and 
Gibbs, 1994). Reactions are adjusted according to the primers, target regions, relative size 
of the target DNA fragments, temperature and other factors suitable for multiplex 
amplification (Edwards and Gibbs, 1994; Koskinen et al., 2009). If multiplex real-time PCR 
is properly optimized, the reliability of the data increases and turn-around time and costs 
are lower compared with conventional and one-species real-time PCR (Edwards and Gibbs, 
1994). 
 
No single PCR protocol is suitable for all situations. In addition to applications 
mentioned here, several others are available (Tang, 2013) and the choice of method is 
determined by the purpose. Different PCR assays need optimization for polymerase 
enzyme, dNTP and magnesium (enzyme cofactor) concentrations and other reaction 
components depending on the purpose (Innis et al., 1990). The primer and oligo designs are 
critical to achieve maximum amplification efficiency. Successfully implemented primers 
are usually protected with patents in commercial PCR assays. Most common problems with 






primers, formation of primer-dimers competing for amplification with target product and 
mutations in target sequences (Innis et al., 1990). In addition, in multiplex real-time PCR, 
annealing conditions for several oligos may not be optimal, increasing the chance of errors 
during the cycle. With PCR applications, the only biological data are the detected target 
DNA fragments.  
2.3.4. Development of the PCR assay for bovine mastitis diagnostics 
 
Different applications of PCR in bovine mastitis diagnostics have been introduced since 
the beginning of the 21st century (Riffon et al., 2001; Phuektes et al., 2001; Gillespie and 
Oliver, 2005; Graber et al., 2007; Koskinen et al., 2009). The joint objective for 
development of a DNA-based molecular diagnostic method was to have a fast test of high 
sensitivity (Se) and specificity (Sp), providing reliable and objective results. 
 
The first two PCR tests designed to detect udder pathogens were a conventional PCR by 
Riffon et al. (2001) and a multiplex PCR assay by Phuektes et al. (2001). Primers designed 
for 23S and 16S rRNA spacer regions were used in both studies. Riffon et al. (2001) tested 
primers for Escherichia (E.) coli, S. aureus, Str. agalactiae, Str. dysgalactiae, Str. 
parauberis and Str. uberis. Electrophoresis was used to detect the amplified PCR products. 
Time used in the test was 4.5 - 6 h depending on whether a pre-PCR enzymatic lysis step 
was included or not. Deleting the pre-PCR enzymatic lysis step decreased the time and 
expenses but lowered the sensitivity of the test from 3.13 x 103 cfu/ml to 5 x 103 cfu/ml 
(Riffon et al., 2001). Phuektes and al. (2001) presented a multiplex PCR assay for 
simultaneous detection of S. aureus, Str. agalactiae, Str. dysgalactiae and Str. uberis. They 
reported detection limits for multiplex PCR from 103 and 104 cfu/ml depending on the 
species and DNA extraction method (Phuektes et al., 2001). Sensitivity of 1 cfu/ml was 
obtained with overnight enrichment protocol. The multiplex PCR was reported to be 
significantly more sensitive than culture for detection of S. aureus and Str. uberis, but no 
significant differences in sensitivities between PCR and culture for the detection of Str. 
agalactiae and Str. dysgalactiae were established (Phuektes et al., 2001). 
 
Gillespie and Oliver (2005) introduced a multiplex real-time PCR assay to detect S. 
aureus, Str. uberis, and Str. agalactiae simultaneously with primers other than 16S and 23S 
rRNA. The sensitivity of this assay to correctly identify S. aureus, Str. agalactiae, and Str. 
uberis directly from milk was 95.5% and specificity was 99.6% (Gillespie and Oliver, 
2005), considering BC as the gold standard. 
 
Graber et al. (2007) used real-time quantitative PCR (qPCR) in detection of only S. 
aureus by targeting the nuc gene (Graber et al., 2007) with analytical sensitivity of 1.15 × 
103 cfu/ml. They reported that qPCR was never negative for S. aureus when the culture 
result was positive and analytical sensitivity was reported over 500 times higher than in 
standard bacteriology (Graber et al., 2007). Correlation between the qPCR results and 






identify chronic S. aureus infections (Studer et al., 2008), where a clear synchrony in the 
shedding curves between qPCR and cfu/ml was reported. Botaro et al. (2013) introduced 
another qPCR assay targeting S. aureus with different quantification chemistry (SYBR 
GREEN instead of TaqMan) reaching detection limits of 1.04 × 101 cfu/ml (Botaro et al., 
2013). 
 
The first commercial multiplex real-time PCR assay for mastitis diagnostics 
(PathoProofTM Complete-12 Kit; Thermo Fisher Scientific, former Finnzymes Oy, Finland) 
was introduced by Koskinen et al. (2009). The test-kit included all the needed reagents for 
DNA extraction and patented primer-mixes and solutions for the PCR. The assay was 
designed to identify staphylococcal beta-lactamase gene (blaZ) and eleven of the most 
common udder pathogens (Corynebacterium (C.) bovis, Enterococcus faecalis/faecium, 
Escherichia (E.) coli, Klebsiella oxytoca/pneumoniae, Serratia (S.) marcescens, 
Staphylococcus (S.) aureus, Staphylococcus spp., Streptococcus (Str.) agalactiae, Str. 
dysgalactiae, Str. uberis and Peptoniphilus (P.) indolicus and/or Trueperella (T.) pyogenes) 
to species or a group level directly from milk, without enrichment protocols. The group 
level identification is based on oligos designed for whole pathogen group (like 
staphylococci, including species and subspecies). Specific additional oligos were designed 
for certain species, like S. aureus, to separate them from the group. The result 
Staphylococcus spp. in PCR results from PathoProofTM thus refers to non-aureus 
staphylococci. The kit included an enzymatic lysis step to disrupt the cell walls of bacteria 
to the extraction protocol, as well as spin column-based DNA purification and elution steps. 
The results were promising as the analytical Se and Sp of the assay from spiked samples 
was 100% for all isolates originating from bovine mastitis and the test was completed in 
four hours (Koskinen et al., 2009).  
Since then, several kits of PathoProofTM Mastitis PCR Assay, including different panels 
of pathogen species, have been launched. The panel currently in routine use in Finland is 
Thermo ScientificTM PathoProofTM Complete-16 Kit, which has replaced the previous 
Complete-12 kit. Complete-16 Kit includes four additional oligos (Mycoplasma spp., M. 
bovis, Prototheca spp. and yeasts) in addition to oligos mentioned above. Dairy producers 
send milk samples with preservatives to laboratories via milk trucks or mail and receive the 
answer usually in 24 hours. Some laboratories send the result of a bacterial DNA finding as 
Ct values, some laboratories provide the result as high (+++), moderate (++) or low (+) 
amount of detected target DNA, based on Ct ranges provided by the manufacturer. To my 
knowledge, only one other commercial multiplex real-time PCR assay, Mastit 4 (DNA 
Diagnostics A/S, Risskov, Denmark), is available to date, including also several different 
panels with slight differences in the target pathogen spectrum. 
2.4. Multiplex real-time PCR in bovine mastitis diagnostics 
Studies on the performance and detection capacity of commercial multiplex real-time 
PCR assays have been published since 2009, often comparing the PCR results with BC 






2010; Spittel and Hoedemaker, 2012; Keane et al., 2013; Steele et al., 2017), cow composite 
samples (Cederlöf et al., 2012; Mahmmod et al., 2013b; Nyman et al., 2016a) and bulk tank 
milk samples (Soltau et al., 2017). Some studies where multiplex real-time PCR has been 
the only diagnostic method are also available from quarter sampling (Vakkamäki et al., 
2017), cow composite sampling (Timonen et al., 2017) and from bulk tank milk (BTM) 
sampling (Katholm et al., 2012).  
2.4.1. Performance and detection capacity of multiplex real-time PCR 
 
The first field study comparing a commercial multiplex real-time PCR assay 
(PathoProofTM Complete-12 Kit) with conventional culture included a set of aseptically 
taken quarter milk samples from healthy, subclinical and clinical cases from Finland and 
The Netherlands (Koskinen et al., 2010). Pathogens were identified and detected from all 
types of mastitis more often with PCR compared with BC (Ct cut-off 37.0) (Table 1). 
Similar results were obtained in Ireland, where clinical mastitis samples from Irish milk-
recording dairy herds were examined with BC and with the same PCR assay and cut-off 
(Keane et al., 2013) (Table 1). In a German study carried out with a comparable PCR assay 
and test panel, quarter milk samples from healthy cows with varying SCC counts were 
examined (Spittel and Hoedemaker, 2012). They reported that PCR detected target DNA 
over twice as often compared with BC, where only 32% of samples were positive in culture. 
A low percentage of positive BC samples was reported to be in line with previous German 
studies (Spittel and Hoedemaker, 2012), though. Vakkamäki et al. (2017) presented data 
from over 240 000 quarter milk samples studied only with multiplex real-time PCR assay 
from dairy cows with suspected mastitis, thus including subclinical and clinical mastitis. 
They reported that 88% of the samples included DNA of at least one target pathogen 
(Vakkamäki et al., 2017).  
Table 1. Proportion of samples positive in multiplex real-time PCR and culture (BC) in studies using aseptically 
taken quarter milk samples. PathoProofTM Complete-12 Kit was used in all studies except Vakkamäki et al. 






Proportion of PCR+ 
samples 
Proportion of BC+ 
samples 
Spittel and Hoedemaker, 2012 681 subclinical 71 % 32 % 
Koskinen et al. 2010 780 clinical 89 % 77 % 
Koskinen et al. 2010 46 subclinical 91 % 83 % 
Koskinen et al. 2010 132 healthy 28 % 17 % 
Keane et al. 2013 141 clinical 92 % 70 % 







Se and Sp for multiplex real-time PCR have been calculated using various methods 
(Table 2). Steele et al. (2016) selected a subset from quarter-based, BC positive samples for 
PCR testing, representing quarters with a current or prior Str. uberis or S. aureus infection. 
Compared with culture, PCR performed better in detecting S. aureus than Str. uberis (Table 
2) (Steele et al., 2017). Agreement between BC and PCR was 74% for S. uberis and 96% 
for S. aureus (Steele et al., 2017). 
 
Table 2. Sensitivities (Se) and specificities (Sp) for multiplex real-time PCR and bacterial culture (BC) in 
detecting different target pathogens from milk samples. Detailed description of the samples and methods are 
presented in the last column. 
 
Target Se PCR Sp PCR Se BC Sp BC Other information 
Steele et al. 20161 S. aureus 96.4 99.7 n/a n/a Quarter based 
samples. Data 
studied with PCR 
comprised of a 
subset from BC+ 
samples. Ct cut-off 
37.0. Se and Sp 
calculated BC as 
gold standard. 
Str. uberis 86.8 87.7 n/a n/a 
Mahmmod et al. 2013b1 S. aureus 91 99 53 89 Cow composite 
samples from 
lactating cows. Ct 
cut-off 39.0. Se and 
Sp calculated with 
Latent Class 
Analysis. 
Cederlöf et al. 20121 S. aureus 61-93 99-93 94-78 90-97 Cow composite 
samples from cows 
at dry-off. Ct cut-offs 
varying from 32 - 
39.0. Most optimal 
Ct cut-off was 
concluded 37.0. Se 
and Sp calculated 
with Latent Class 
Analysis. 
Nyman et al. 2016a1 S. aureus 91 96 65 90 Lactating cows. Cow 
composite samples 
were used for PCR 
and quarter based 




Str. dysgalactiae 80 98 75 98 
Str. uberis 95 98 75 98 
NAS2 75 85 60 80 






Se and Sp of PCR against culture have also been studied using cow composite milk 
samples (Cederlöf et al., 2012; Paradis et al., 2012a; Mahmmod et al., 2013b; Nyman et al., 
2016a). Mahmmod et al. (2013b) compared the test characteristics of PathoProofTM Mastitis 
PCR Assay, BC and CMT in diagnosing S. aureus. They examined 609 routine DHI samples 
of six herds with parlour milking. They estimated Se and Sp of PCR and BC in diagnosing 
S. aureus using latent class analysis (LCA), where PCR outperformed BC (Mahmmod et 
al., 2013b) (Table 2). Cederlöf et al. (2012) studied also the diagnostic characteristics of the 
same PCR assay and BC in diagnosing S. aureus from composite samples, but instead of 
lactating cows they tested cows at dry-off. LCA was used to estimate Se and Sp of PCR 
with different cut-offs for PCR. They concluded that the most optimal cut-off for PCR was 
37.0 (Cederlöf et al., 2012). Nyman et al. (2016a) compared PCR results of cow composite 
samples with culture results from aseptically taken quarter milk samples, estimating Se and 
Sp for several different target pathogens (Table 2). The aseptic quarter milk samples of all 
quarters of the cow were collected over three consecutive days and PCR samples only on 
day two. They reported that Se of PCR was higher than that of BC for all investigated 
bacteria if only parallel samples of the second day were tested. If the three consecutive 
samples were included in BC, Se of BC was numerically higher compared with PCR for 
only S. aureus. They concluded that using non-aseptically collected milk samples increases 
Se (although not always significantly), while Sp is kept on a similar level or lower 
(sometimes significantly lower), compared with BC of aseptically collected milk samples 
(Nyman et al., 2016a). 
 
Paradis et al. (2012) used a different, non-commercial multiplex real-time PCR assay, 
detecting S. aureus, Str. uberis, E. coli and Str. agalactiae, and assessed the samples 
according to severity of mastitis. They concluded that Se of PCR was higher than Se of BC 
in samples from healthy quarters, but lower than BC in clinical mastitis samples using latent 
class analysis (Paradis et al., 2012). They also reported that detection capacity of PCR was 
reduced for E. coli and Str. agalactiae from nonclinical samples, when the age of sample 
increased (Paradis et al., 2012). Due to the differences in methodologies, these results are 
not applicable to results obtained with other PCR assays. Another commercial multiplex 
real-time PCR assay with oligos for S. aureus, Str. agalactiae, Str. uberis and M. bovis 
(Mastit 4B) was used by Timonen et al. (2017), where routine DHI samples were examined 
to identify the within herd prevalence of M. bovis in one large Estonian herd. They detected 
DNA of at least one of the target pathogens in 38% of cow composite samples (Timonen et 
al., 2017). 
 
Multiplex real-time PCR has been used also to study BTM samples. Katholm et al. 
(2012) used a PathoProofTM Complete-12 Kit in defining the quality of Danish BTM 
samples of over 4 200 herds. They concluded that low Ct values (defined as <32.0) for S. 
aureus, Str. uberis, Str. dysgalactiae and Str. agalactiae correlated with high BTM SCC, 
with the strongest correlation for S. aureus and S. uberis (Katholm et al., 2012). They also 
stated that PCR could be used similarly as culture methods in monitoring BTM samples, 
especially for Str. agalactiae (Katholm et al., 2012). Four different species were detected in 






from several different sources in addition to one or more possibly infected quarters. In 
addition, this study showed that 95% of samples were positive for Str. uberis DNA and 91% 
for S. aureus DNA. In addition to being major mastitis pathogens, Str. uberis is present, for 
example, in cow manure (Klaas and Zadoks, 2017) and S. aureus is a common inhabitant 
of the skin (Barkema et al., 2006). Despite the test panel used, BTM samples leave the origin 
of the detected pathogen completely open. Detecting DNA of rare, highly contagious major 
pathogens, like M. bovis in Nordic countries, the DNA detection from BTM may be of more 
diagnostic value and lead to cow level screening for positive carrier animals. 
 
Justice-Allen et al. (2011) compared capacity of PCR for detection of M. bovis with BC 
from BTM samples. They used SYBR Green chemistry in their PCR assay. Despite 
numerically higher Se for PCR (78%) compared with BC (70%), the difference was not 
significant. The agreement between the test methods was nearly 80% (Justice-Allen et al., 
2011). In a recent study by Soltau et al. (2017) BTM samples were used to estimate the 
apparent within herd prevalence for major pathogens (S. aureus, Str. uberis, Str. agalactiae 
and Str. dysgalactiae) with a commercial multiplex real-time PCR (Mastit 4B) compared 
with BC. PCR was concluded to outperform BC on herd level sensitivity (Soltau et al., 
2017). With a probability threshold of 90%, one positive BTM sample per herd for the 
pathogen indicated a cow level prevalence of 28% for S. aureus, 9% for Str. dysgalactiae 
and 14% for Str. uberis (Soltau et al., 2017). 
2.4.2. Number of detected species per sample 
 
Some studies on milk microbiota have revealed a great diversity of microbial species in 
mastitic milk samples, but their clinical relevance remains completely open (Oikonomou et 
al., 2012). The current concept is that intramammary infection is caused by one or a 
maximum two species (Middleton et al., 2017; Rainard, 2017) despite the debated 
hypotheses about mastitis being related to dysbiosis of the mammary gland (Addis et al., 
2016). Consequently, samples with more than two species are considered to be 
contaminated in BC (Middleton et al., 2017). No agreed consensus for contamination for 
multiplex real-time PCR results is available and currently all detected target pathogens are 
reported to the client.  
 
The proportion of positive PCR samples containing more than two target pathogens has 
varied according to the country and type of mastitis (Koskinen et al., 2010; Spittel and 
Hoedemaker, 2012; Keane et al., 2013; Vakkamäki et al., 2017), but with the contamination 
definition of BC, most of the samples have been of good quality (Table 3). In Finland, with 
data covering over 240 000 routine quarter milk samples taken mostly by farmers, 74.2% 
of the samples contained only one or two pathogens (Table 3) and 13.4% of samples 
included DNA of three or more target pathogens (Vakkamäki et al., 2017). The most 
prevalent target pathogens from these samples were Staphylococcus spp. and C. bovis. T. 
pyogenes/P. indolicus was also a frequent finding in multispecies samples (Vakkamäki et 






aseptic milk samples were collected in two countries. Proportion of positive PCR samples 
with two or more species was 24.7% (137/554) compared to culture results where 11.1% 
(65/540) had two or more species (Koskinen et al., 2010). Bexiga et al. (2011a) reported a 
4-6% prevalence of multispecies samples. Only three samples (2.0%) included three target 
pathogens in a study from Ireland (Keane et al., 2013) (Table 3). 
 
Table 3. Percentage of samples where no (0) target pathogen DNA was detected and samples containing 
target DNA of 1 - 5 different species per sample of aseptically taken quarter samples, studied with real-time 
PCR (PathoProofTM Complete-12 or Complete-16 Kit). 
 
   Number of species per sample (%) 
 N, total Mastitis 0 1 2 3 4 ≥5 
Koskinen et al. 20101 132 healthy 72 22.7 4.5 0.8   
Spittel et al. 20121 681 subclinical 29.4 39.8 24.2 5.5 0.7 0.3 
Koskinen et al. 20101 46 subclinical 8.7 58.7 21.7 10.8   
Koskinen et al. 20101 780 clinical 11.4 40.7 30.3 17.6   
Keane et al. 20131 141 clinical 8 63 27 2   
Vakkamäki et al. 20171,2 240 067 variable 12.4 49 25.2 9.2 2.9 1.3 
1 PathoProofTM Mastitis Complete-12 Kit 2 PathoProofTM Mastitis Complete-16 Kit 
 
 
Timonen et al. (2017) reported that 61% of cow composite samples contained only one 
species, 31% contained two and 8% three species, but their test kit included only four major 
pathogens: M. bovis, Str. agalactiae, S. aureus and Str. uberis. They used True-Test 
automatic sampling device (Timonen A., personal communication 11/2017). If kits with 
broader spectrum were to have been used, the numbers would probably have been much 
higher for the multispecies samples. In BTM samples, 90% of the samples included four 
pathogens with a Ct cut-off of 40.0 (Katholm et al., 2012).  
2.4.3. Dominance 
 
The semi-quantitative feature of the multiplex real-time PCR enables reporting a 
possible dominance of a particular pathogen over the others. Vakkamäki et al. (2017) 
reported that in 25.2% of the PCR positive samples, two species were detected. Dominance 
(>90% of the total target DNA in the sample) was reported for 66.2% of the double-species 
samples. The most common dominant species was Staphylococcus spp. (non-aureus 
staphylococci, NAS) (40.2% of samples), followed by Str. dysgalactiae (16.7%), S. aureus 
(14.4%) and Str. uberis (10.0%) (Vakkamäki et al., 2017). Species accompanying most 
often the dominant species were C. bovis, Staphylococcus spp., yeasts, T. pyogenes/P. 
indolicus, and S. aureus. In contrast S. dysgalactiae and S. uberis were the most prevalent 






2.4.4. Prevalence of different species 
 
Some mastitis surveys have used PCR to study the microbiological etiology of mastitis. 
Prevalence of the most common pathogens reflects the situation of the country and does not 
essentially differ from earlier studies that used conventional BC. Reported prevalence varies 
also according to definitions used: most studies report the proportion of species out of single 
species samples or out of the total number of positive samples. In a Finnish study by 
Vakkamäki et al. (2017), the most common pathogens were Staphylococcus spp. (43%) and 
S. aureus (21%) in samples where only one species was present. Mean Ct values were 31.5 
for Staphylococcus spp. and 28.0 for S. aureus (Vakkamäki et al., 2017). In Germany, Spittel 
and Hoedemaker (2012) reported C. bovis (45.2%) and Staphylococcus spp. (41.3%) as the 
most common bacteria among single bacteria detections, S. aureus being present in 16.9% 
of those samples. Among all PCR positive samples, the proportion of Staphylococcus spp. 
findings was 34.5%, Coryneforms 47.7% and S. aureus 9.5%. In the Irish study by Keane 
et al. (2013) S. aureus presented 37%, Str. uberis 25% and E. coli 18% of the samples 
containing only one pathogen. The prevalence of Staphylococcus spp. was low (4%) (Keane 
et al., 2013). 
 
Katholm et al. (2012) studied Danish BTM samples with PCR using the highest possible 
Ct cut-off, 40.0 (PathoProofTM Complete-12 Kit). DNA of Staphylococcus spp. was 
detected from every sample, DNA of Str. uberis was detected in 95%, S. aureus in 91% and 
C. bovis in 90% of the samples (Katholm et al., 2012). Str. agalactiae was identified from 
7% of samples.  
2.4.5. Culture negative samples examined with PCR 
One of the first studies comparing the detection capacity of PCR and conventional 
culture aimed to investigate culture negative samples with multiplex real-time PCR 
(Taponen et al., 2009). Of the 79 culture negative milk samples, originating from clinical 
mastitis cases, 43% were positive in PCR, all containing common mastitis pathogens. Ct 
values were reported to vary between of 22.2 - 36.7 in positive samples, indicating 2 x 103 
to 107 genome copies per ml of milk (Taponen et al., 2009). Koskinen et al. (2010) reported 
that 76% of culture negative (detection limit in BC 100 cfu/ml) samples originating from 
clinical and subclinical samples were positive for at least some target pathogen DNA in 
PCR, using the same assay as Taponen et al. (2009). Bexiga et al. (2011a) tested samples 
with SCC over 500 000 cells/ml with either culture negative or culture positive for single 
minor pathogen isolates with PCR. From no-growth samples, 47% was PCR positive. In a 
German study, target DNA was detected in 57.8% of BC negative samples (Spittel and 
Hoedemaker, 2012). In Ireland, 79% of the culture negative samples were PCR positive 
(Keane et al., 2013). Culture negative PCR positive results have mostly contained CNS 
(Taponen et al., 2009; Koskinen et al., 2010; Bexiga et al., 2011a; Spittel and Hoedemaker, 
2012) and C. bovis (Koskinen et al., 2010; Bexiga et al., 2011a; Spittel and Hoedemaker, 






2012; Keane et al., 2013) and Str. dysgalactiae were also reported. The BC-/PCR+ results 
have also included several major pathogens, like S. aureus (Taponen et al., 2009; Koskinen 
et al., 2010; Spittel and Hoedemaker, 2012) and Str. agalactiae (Koskinen et al., 2010) and 
E. coli (Bexiga et al., 2011a). Keane et al. (2013) reported that the amount of DNA detected 
with PCR was lower in culture negative than in culture positive samples and stated a need 
for further studies to establish the role of bacterial quantification for defining clinically 
relevant PCR results. Based on knowledge to date, quantification of bacterial DNA and its 
relation to clinical severity of mastitis needs further studies.  
2.4.6. PCR negative samples positive in culture 
PCR negative results, with culture positive identifications are rare, ranging from 2.0% 
(Keane et al., 2013) to 5.6% (Koskinen et al., 2010) and 6.8% (Spittel and Hoedemaker, 
2012). In a study by Koskinen et al. (2010), 93.0% of the microbes cultured from PCR 
negative samples were not included in the test panel of the PCR assay. Spittel and 
Hoedemaker (2012) also cultured microbes belonging to the test panels, including 
Staphylococcus spp., from PCR negative samples. They listed several reasons for PCR 
negative samples: BC positive samples like bacterial number below the PCR detection limit, 
polymorphism in the PCR target region or contaminated culture plate. Bexiga et al. (2011a) 
reported one case where PCR targeted S. aureus and BC identification result was for S. 
intermedius. In this case, the authors suggested that the misclassification was more likely 
an error of the biochemical test in phenotypic identification instead of PCR (Bexiga et al., 
2011a). Keane et al. (2013) reported that distribution of PCR targets did not differ between 
results obtained from culture negative and culture positive samples. The exception was S. 
aureus, which was detected more frequently in culture positive samples than in culture 
negative samples (Keane et al., 2013). 
2.4.7. Beta-lactamase gene (blaZ) 
The presence of the staphylococcal blaZ gene, encoding resistance to beta-lactam 
antibiotics, is automatically reported in PCR results when it is detected in the milk sample 
(PathoProofTM Complete-12 Kit and Complete-16 Kit; Mastit-4 Tests M4D, M4BD and 
M4BDF). The origin of blaZ detected from a sample cannot be determined or linked to a 
specific target pathogen. Pitkälä et al. (2007) studied beta-lactamase production from a total 
of 175 staphylococcal isolates, originating from bovine mastitis samples and dogs. They 
tested five commercial beta-lactamase tests, the clover leaf test and PathoProofTM 
Complete-12 Kit. They concluded that PCR was the most reliable test compared with the 
reference test (Pitkälä et al., 2007). Keane et al. (2013) used the same PCR assay and 
reported of 93% agreement between blaZ and phenotypic tests for all staphylococci in the 







Spittel and Hoedemaker (2012) reported 37.0% of CNS and 27.7% of S. aureus to 
possess blaZ, which was higher than those reported before in German surveys, which had 
used conventional methods (Spittel and Hoedemaker, 2012). They did not confirm the PCR 
results with any conventional methods. A study from Ireland with 40.0% of blaZ positive 
staphylococci reported that the obtained figures were in agreement with previous reports, 
relying on conventional methods (Keane et al., 2013). In BTM samples, BlaZ was detected 






3 Aims  
The aim of this research was to provide knowledge to improve the interpretation of 
bovine mastitis diagnostics done with multiplex real-time PCR by  
 
1) comparing results of a commercial multiplex real-time PCR assay and BC 
from natural and experimental IMI and 
2) evaluating how the quarter milk sampling technique affects the multiplex real-







4 Materials and Methods  
4.1. Study designs and data 
This thesis comprises results from four independent studies (I-IV). In studies I and IV, 
microbiological results from mastitic milk samples analyzed with multiplex real-time PCR 
(later referred only as PCR) were compared with results from the current reference method 
of conventional bacterial culture (BC). In studies II and III, the effect of two different milk 
sampling methods on PCR results were evaluated. 
 
The data for study I derived from 294 routine quarter milk samples, collected by farmers 
and local veterinarians and sent to the regional laboratory of the largest Finnish dairy 
processor (Valio Oy, Lapinlahti, Finland) between October 2010 and January 2011. 
Samples originated from naturally occurring, subclinical or clinical mastitis cases during 
the defined time period. Samples were included to the study in the order of arrival and no 
selective measures were carried out. The study was a cross-sectional study, analysing data 
collected routinely at a defined time.  
 
Data for study II were collected in Estonia during two separate sampling visits in 
November 2012 and in June 2013. A total of 113 quarters from 53 cows of two large 
Estonian dairy herds were sampled with two different techniques: conventional aseptic milk 
sampling and experimental needle sampling. Cows were initially enrolled in the study based 
on cow composite SCC values of >200 000 cells/ml in the most recent DHI results. Ninety-
nine quarters included in the study had high SCC according to CMT tests on site (CMT >2). 
Twenty-two quarters out of the total 113 had CMT of one, and were sampled to represent 
healthy quarters. Parity of the cows and average milk production of the herds were recorded. 
The farms belonged to client herds of the Large Animal Clinic of the Estonian University 
of Life Sciences. The study was an experimental study to validate our two hypothesis that 
avoiding the teat orifice and teat duct completely would reduce the number of clinically 
irrelevant potential contaminants in the milk sample. Experimental sampling procedure was 
approved by the Commission of Animal Trials at the Estonian Ministry of Agriculture (No 
7.2–11/1). Samples were collected by the authors. 
 
Data for study III comprised quarter milk samples collected on 44 commercial dairy 
farms belonging to the practice area of the Production Animal Hospital of the Faculty of the 
Veterinary Medicine (University of Helsinki), between March 2011 and April 2013. Cows 
with mastitis suspected or detected by the farm staff were sampled during farm visits in the 
conventional aseptic manner and experimentally with a sterile teat cannula. Each additional 
cannula sampling was approved by the owner. CMT in the quarters enrolled in the study 
was >2 on a scale of 1-5 (Klastrup and Schmidt Madsen, 1974). Additional data comprised 
clinical signs, breed, date of birth, parity and the last date of calving. All samples were 
collected by the veterinarians and veterinary students of the Production Animal Hospital. 






Data for study IV originated from an experimental challenge conducted at the Production 
Animal Hospital of the Faculty of the Veterinary Medicine (University of Helsinki, 
Mäntsälä) between January and May in 2008. Eight clinically healthy, primiparous and mid-
lactating cows were infected with Staphylococcus simulans and S. epidermidis in a 
crossover study of four periods. One period included a two-week sampling period after the 
inoculation and a two-week wash-out period. Test quarters were sampled a week before 
inoculation in two consecutive samplings to ensure IMI-free status of the quarter with BC. 
No bacterial growth was detected in culture. SCC of the test quarters were <100 000 cells/ml 
and another healthy quarter of the cow served as a control. Experimentally infected quarters 
did not serve as test quarters again in following challenge periods. If quarters were positive 
in bacterial culture at the last sampling at 336h post challenge (PC), intramammary 
antibiotic were administered. S. simulans quarters were treated once a day for three days 
with procaine penicillin (Carepen®600mg, Vetcare Finland Oy). S. epidermidis quarters 
were treated accordingly with cloxacillin (Wedeclox mastitis® 1000mg, WDT, Germany). 
The treatments were chosen based on susceptibility testing. Treated quarters were tested and 
confirmed negative in bacterial culture in three consecutive samplings 11, 12 and 13 days 
post-treatment. All samples were collected, cultured and examined by authors Hiitiö, 
Simojoki and Taponen. Experimental infection (IV) was approved by the Ethics Committee 
of the University of Helsinki (HY 88-06). Preparation of the inoculates was described in 
Simojoki et al. (2011). 
 
In the experimental studies,  sample sizes were impacted by the availability of cows and 
budgetary limitations. 
4.2. Cows and herds 
More detailed information of the herds and cows of the studies is presented in Table 4. 







Table 4. Basic information for the sampled cows, herds they were in and sample numbers in studies I – IV. 
 
Study I II III IV 
Total number of samples 294 226 149 280 
Number of sampled cows n/a1 53 88 8 
Number of sampled quarters 294 113 149 14 
     
Number of herds  n/a 2 44 1 
Size of the herds n/a 420, 700 7-114 
 
Type of the barn n/a Tie-stall Tie-stall,     
Free-stall 
Tie-stall 
Bedding material n/a Straw Saw dust, 
Peat, Straw 
Saw dust 





Average parity (median) n/a 3 3 1 
Average milk yield of the cow (kg) n/a 27.6 n/a 3.83 
1 Information was not available 
2Ho=Holstein, NR=Nordic Red, including registered as Ayrshire breed, Other= Mixed breeds, Finncattle and 
Jerseys 
3Average milk yield of a quarter.  
  
4.3. Milk sampling protocols 
Two experimental sampling techniques were used to collect a quarter milk sample: 
sampling with a needle and vacuum tube (II) and sampling with a cannula (III), in addition 
to the conventional aseptic technique (I-IV). Sampling took place at random time points 
related to milking (I, III), prior to milking (IV) or within two hours of milking (II). 
4.3.1. Aseptic milk sampling (I-IV) 
Quarter milk samples were taken according to the internationally agreed guidelines 
(Middleton et al., 2017, Fig 1). Teats and udders were first cleaned with cotton towels if 
visibly dirty (II-IV) and foremilk was stripped. CMT was conducted for each test quarter 






1974). Aseptic milk sampling (II-IV) was conducted according to the international 
guidelines (Hogan et al., 1999). The teat end was scrubbed with cotton moistened in 70% 
ethanol, at least three times or until visibly clean. A few strips of milk were discarded and 
the sample was milked into a 10 ml plastic milk tube without preservatives. The sampler 
wore disposable gloves (II-IV). This sampling protocol has been introduced and well 
adopted in Finland, yielding good quality samples (Vakkamaki et al., 2017), and we may 
assume that most quarters also in study I were sampled accordingly.  
 
 
Fig 1.  Aseptic milk sampling technique. 
 
4.3.2. Needle sampling (II) 
The sampling protocol was designed to obtain milk directly from the udder cistern (Sinus 
lactifer, pars glandularis (Schaller, 1992), to avoid possible contamination sources from the 
teat and related anatomical parts. Prior to sampling, the cows were sedated lightly with an 
intravenous dose of xylazine (0.02 mg/kg, Rompun 20 mg/ml, Bayer Animal Health GmbH, 
Germany) and 0.5 ml of oxytocin (Vetox 10 IU/ml, Vetcare Oy, Finland) was 
simultaneously administered intravenously to induce milk ejection. The site of puncture was 
randomly chosen by the sampler, targeting the easiest puncture line possible and avoiding 
visible veins (Fig 2). An area of about 3 x 3 cm at the puncture site was scrubbed with 
cotton, moistened in 70% ethanol, at least three times or until visibly clean. After cleaning 
the site, the sampler wore a new pair of plastic disposable gloves. A 20-Gauge double-ended 






the puncture aimed towards the udder cistern. After placing the needle, a 9 ml vacuum tube 
without preservatives (Vacuette Tube Z, Greiner Bio-One, Monroe, NC) was attached and 
the milk sample was drawn into the tube. The needle was removed and the site pinched or 
pressured for a while if bleeding was apparent. Needle samples were taken immediately 




Fig 2. Needle sampling technique. 
 
4.3.3. Cannula sampling (III) 
The aim of the technique was to bypass the teat orifice and teat canal to collect the milk 
from the teat cistern (Sinus lactifer, pars papillaris; Schaller, 1992). In addition to 
disinfecting the teat for conventional sampling, the teat end was scrubbed again in a similar 
manner with 70% ethanol before inserting the teat cannula (Fig 3). Cannulas were 
individually packed, sterile teat cannulas 42 mm in length (Teat cannula, Vetcare Finland 
Oy). Milk was allowed to flow freely into a plastic milk tube without preservatives 
(Linkoputki 16 x 100mm Plastone, Mekalasi Oy, Finland). The sampler wore a new pair of 
disposable gloves before inserting the cannula. The cannula samples were taken after 







Fig 3. Cannula sampling technique. 
 
4.4. Inoculation and test protocol in experimental challenge 
(IV) 
S. simulans and S. epidermidis strains of the inoculate originated from natural persistent 
infections. The strains were identified with API Staph ID 32 (bioMérieux, Marcy l’Etoile, 
France) and amplified fragment length polymorphism (AFLP). One challenge dose 
contained 5.7 × 106 cfu in 7 ml of saline. The inoculation was done on day zero, thirty 
minutes after the morning milking. At every sampling, a few strips of foremilk were 
discarded first, followed by visual inspection of the milk on a CMT plate and CMT testing. 
Aseptic milk samples for bacteriological culture, PCR testing and SCC determination were 
collected at 0, 4, 6, 12, 21, 27, 30, 36, 45, 54, 69, 78, 93, 102, 117, 126, 141, 168 (7 d), 240 
(10 d) and 336 hours (14 d) post-challenge (PC). Sampling was carried out always prior to 
milking. 
4.5. Transportation and handling of milk samples (I-IV) 
Samples in study I were sent to the regional laboratory of Valio Ltd. (Lapinlahti, 






transported refrigerated to the national mastitis reference laboratory, Finnish Food Safety 
Authority Evira (Kuopio, Finland). Samples were cultured on arrival. Two aliquots were 
separated and frozen to -20 °C immediately after bacterial culture. 
 
In Estonia (II), sampling took place before noon. Samples were cooled on ice and 
transported in cooler boxes to the laboratory of the Department of Production Animal 
Medicine (Faculty of Veterinary Medicine, University of Helsinki, Finland) within 8 hours 
from sampling and stored in a refrigerator at 6 °C. The following morning, samples were 
cultured. In addition, two 2.5 ml milk aliquots were drawn aseptically from all samples 
(Vacuette Tube Z, 4 ml) and stored at -20 °C for PCR and milk N-acetyl-β-D-
glucosaminidase (NAGase) activity determination.  
 
Samples for study III were transported to the laboratory (Department of Production 
Animal Medicine, University of Helsinki) within four hours of sampling. Samples were 
cultured to obtain a BC result for the client. Those results were not included in study III. 
For PCR, carried out later, 2.5 ml of milk was separated and stored at -20 °C in milk tubes 
(Vacuette Tube Z, 4 ml, Greiner Bio-One).  
 
Milk samples from experimental infections (IV) were cultured after sampling and 
aliquots were frozen at -80 °C for PCR and other purposes.  
 
No preservatives were included in any of the milk samples (I-IV). 
4.6. Bacterial culture (I, IV) 
Milk samples were cultured in two studies included in this thesis, studies I and IV. 
Culturing in study I was carried out at the Finnish Food Safety Authority Evira (Kuopio, 
Finland) and samples of the experimental infection (IV) were cultured in the laboratory of 
the Department of Production Animal Medicine (Faculty of Veterinary Medicine, 
University of Helsinki, Finland). 
 
Bacterial cultures in Evira (I) were carried out in an in-depth manner, where all colony 
forming units (cfu) were enumerated and identified if possible, also from samples containing 
>2 species, which would normally be defined as contaminated (Middleton et al., 2017). 
Morphologically different colonies were counted and identified with suggested protocols 
(Middleton et al., 2017). Gram staining, catalase test, oxidase test (Pro-Lab Diagnostics, 
Richmond Hill, ON, Canada), API Staph, API ID32 Strep, API 20 E and API Coryne 
(bioMérieux, Marcy l’Etoile, France) were used in the identification schemes. For 
Staphylococcus spp., a positive coagulase test (BBLTM Rabbit plasma, BD Diagnostics, 
USA) was confirmed with API Staph (bioMérieux, Marcy l’Etoile, France). Eosin 
methylene blue agar (EMB) (Oxoid, Basingstoke, Hampshire, UK) was used for detection 
of E. coli and TSA was supplemented with Tween-80 (0.1%) (Amresco, Solon, OH, US) 







The volume of cultured milk was 0.01 ml in study I and 0.1 ml in study IV. In both 
studies, milk was spread using a conventional loop over the entire 9 cm plate and incubated 
at 37°C for 48 hours. Additionally, in study IV, several dilutions of milk were cultured to 
ensure correct colony counts in samples suspected of having large numbers of colonies. 
Plates were inspected at 24 and 48 hours. If colony count exceeded 100 on a plate, those 
colonies were recorded as 100 in study I. In experimental study IV number of cfu was 
counted using dilution series. Consequently, the detection limit was 100 cfu/ml (I) or 10 
cfu/ml (IV). An additional higher detection threshold (500 cfu/ml) for a positive result was 
used for coagulase negative staphylococci (I). 
 
In study IV, especially on plates where growth was dense, the morphology or the size of 
the colonies can vary. Morphologically different colonies on sample plates observed during 
the study were identified as coagulase negative staphylococci with standard identification 
schemes mentioned above and checked with API Staph ID 32 test (bioMérieux) (Simojoki 
et al., 2011). The API Staph profiles were compared with the API Staph profiles from the 
original AFLP confirmed S. epidermidis and S. simulans strains used in challenge. 
 
4.7. Indicators for inflammation 
Somatic cell count (SCC, II-IV) and N-acetyl-β-D-glucosaminidase (NAGase, I) 
activity of the quarter milk were used as indicators of inflammation. Cow composite milk 
SCC from DHI samples were also used as selection criteria in enrolment of the cows (II).  
4.7.1. Somatic cell count, SCC 
 
SCC were evaluated with CMT (II-IV) on a scale of 1-5 (Klastrup and Schmidt Madsen, 
1974) on site. More precise results for SCC were determined using the optical DeLaval cell 
counter DCC (II, III) (DeLaval Inc., Tumba, Sweden) or a fluoro-optical method using the 
Fossomatic instrument (Valio Ltd Laboratories, Finland) (IV). The upper quantification 
limit of Fossomatic SCC analysis was 10 × 106 cells/ml. 
4.7.2. N-acetyl-β-D-glucosaminidase activity in the milk 
 
NAGase activity of the milk samples was determined in the laboratory of the Department 
of Production Animal Medicine (University of Helsinki, Mäntsälä, Finland) using an in-
house microplate modification (Hovinen et al., 2016) of the fluorogenic method (Mattila 
and Sandholm, 1985). The results were expressed as picomoles of 4-MU/min/µl milk at 25 
°C. The maximum detection limit of NAGase activity is 24.49 pmol 4-MU/min/µl milk. The 






0.45 pmol 4-MU/min/µl milk (range 0.09–1.04 pmol 4-MU/min/µl milk) (Hovinen et al., 
2016). The definition of mastitic milk in study I was the result exceeding the upper range 
value for normal milk (>1.04 pmol 4-MU/min/µl milk).  
 
4.8. Multiplex real-time PCR (I-IV) 
All samples for PCR were examined at the laboratory of Thermo Fisher Scientific Ltd. 
(Vantaa, Finland) by the manufacturer of the PathoProofTM Mastitis PCR assay (I-IV). 
Samples were delivered to the laboratory deep frozen and thawed before the PCR analysis. 
Two different kits, PathoProofTM Mastitis Complete-12 Kit (I, IV) and PathoProofTM 
Mastitis Complete-16 Kit (II, III), were used. Kit components and PCR machinery 
compatible with PathoProofTM Mastitis was used according to the instruction manuals 
(Thermo Fisher Scientific). All the samples were delivered to the PCR laboratory labelled 
only by ID number of the sample. No information on the origin, background or sampling 
technique was given to the laboratory.    
4.8.1. Target pathogens 
 
Oligos of the Mastitis Complete-12 Kit are designed to target DNA of the following 
species or group of species: C. bovis, Enterococcus spp. including Enterococcus faecalis 
and E. faecium, E. coli, Klebsiella spp. including K. oxytoca and K. pneumoniae, S. 
marcescens, S. aureus, Staphylococcus spp. (non-aureus staphylococci), Str. agalactiae, Str. 
dysgalactiae, Str. uberis, T. pyogenes and/or P. indolicus. PathoProofTM Mastitis Complete-
16 Kit includes additional oligos for M. bovis, Mycoplasma spp., Prototheca spp., and 
yeasts. In addition, both test kits have oligos for staphylococcal beta-lactamase gene (blaZ). 
 
Enterococcus spp., Klebsiella spp., Mycoplasma spp., Prototheca spp. and 
Staphylococcus spp. were identified to group level. PathoProofTM Mastitis Complete Kits 
have joined oligos for Mycoplasma spp. and for Staphylococcus spp. In addition, specific 
oligos for S. aureus and Mycoplasma bovis are included. To differentiate Staphylococcus 
spp. from S. aureus positive sample, or a Mycoplasma spp. from a M. bovis positive sample, 
a 3-cycle difference in their Ct values is required. PathoProofTM Mastitis PCR Assay reports 
non-aureus staphylococci (NAS) as Staphylococcus spp. Thus, Staphylococcus spp. results 
from PCR throughout this thesis are considered as non-aureus staphylocci without 
exceptions.  
4.8.2. Sample volume and reactions 
 
The sample volume used in PCR was 350 µl, which was concentrated to 100 µl in the 






extracted DNA was used in PCR. In both PathoProofTM Mastitis Complete Kits microbial 
targets are divided into four reactions, leading to a volume of 5 µl of extracted DNA solution 
in every reaction. Each reaction detects three (Complete-12) to four targets (Complete-16) 
and an internal amplification control (IAC). In the Complete-12 Kit, targets are divided into 
four reactions as follows: S. aureus, Enterococcus spp., C. bovis and an IAC (reaction 1), 
blaZ, E. coli, S. dysgalactiae, and an IAC (reaction 2), Staphylococcus spp., S. agalactiae, 
S. uberis and an IAC (reaction 3) and Klebsiella spp., Serratia marcescens, T. pyogenes/P. 
indolicus and an IAC (reaction 4). 
 
In PathoProofTM Complete-16 Kit the first reaction primer mix includes oligos for S. 
aureus, Enterococcus spp., C. bovis, M. bovis and an IAC, second reaction oligonucleotides 
for blaZ, E. coli, S. dysgalactiae, Mycoplasma spp. and an IAC. Reaction three contains 
oligos for Staphylococcus spp., S. agalactiae, S. uberis, Prototheca spp. and an IAC and 
fourth reaction oligos for Klebsiella spp., Serratia marcescens, T. pyogenes/P. indolicus, 
yeast and an IAC.  
 
IAC template DNA was included in every reaction. According to the manufacturer, if 
IAC in reaction is not in the acceptable range, an error in the process is suspected and the 
PCR is run again or the sample is prepared from the start. In addition, if negative controls 
yield a positive result, laboratory contamination should be suspected and the sample tested 
again. Every PCR run included at least one negative control (Thermo Fisher Scientific Ltd., 
2017). Samples should be retested also if fluorescence curves are not optimal, indicating a 
possible error in the process. Study samples were assessed according to these guidelines 
(personal communication 2017, Mika Silvennoinen Thermo Fisher Scientific Ltd.). 
4.8.3. Cycle threshold values 
 
Maximum Ct value, i.e. a maximum of cycles in PCR test, was 40.0 (I-IV) for each 
species or group and the blaZ gene reported to an accuracy of one decimal place. A 
definition for a positive result in routine use of the PCR assay is a Ct value of £37.0 (I, III). 
In addition to Ct 37.0, two other cut-offs of 34.0 (II, IV) and 40.0 (II) and their effects on 
results were tested.  
 
The tested cut-off values of 34.0, 37.0, and 40.0 were chosen because Ct 40.0 represents 
the maximum detection limit and Ct 37.0 is the routine cut-off limit in the PathoProofTM 
Mastitis PCR Assay. A Ct limit of 34.0 should show a similar decline in the amount of 
amplified DNA from Ct 37.0 as the decline from Ct 40.0 to 37.0. An approximately 3.3-
cycle difference in Ct values translates to a ~10-fold difference in the concentration of the 
target DNA. 
 
In PathoProofTM Mastitis software, Ct ranges for low, intermediate and high amount of 
detected DNA have been created for each target pathogen. These interpretation ranges are 






4.8.4. Genome copy numbers 
 
Ct values were converted into genome copy (gc) numbers for comparison with bacterial 
culture results (cfu/ml) (I, IV). Gc/reaction were provided by Thermo Fisher Scientific 
according to the authors’ request. Ct values were transformed into genome copy numbers 
using the following formula: genomic copy number per reaction = 10(Ct−x)/y, where Ct = 
cycle threshold value, x = slope of a standard curve and y = intercept of a standard curve. 
The formula does not take into account possible differences in target gene or DNA fragment 
copy numbers within a genome. 
4.9. Data analyses 
4.9.1. Sensitivities and specificities (I) 
Relative specificity (Sp) and sensitivity (Se) for PCR were calculated using bacterial 
culture as the reference (gold standard) in diagnosing S. aureus and Staphylococcus spp. in 
study I. For the calculation, BC results and PCR results were converted into binary 
outcomes, positive intramammary infection (IMI) yes (1) or no (0). Only samples including 
one or two species were included and contaminated culture samples and the respective PCR 
samples were excluded from these calculations (n=256, I). Definition of a positive result for 
S. aureus was 100 cfu/ml and for Staphylococcus spp. 500 cfu/ml, based on the national 
recommendations (Honkanen-Buzalski and Seuna, 1995).  
 
PCR results were considered IMI positive (1) when the Ct value of the targeted pathogen 
was ≤37.0 and negative (0) when Ct value exceeded 37.0 (I). If the sample included both 
Staphylococcus spp. and S. aureus, according to previous definitions, the sample was 
recorded as S. aureus positive and Staphylococcus spp. positive (I). 
 
Predictive values, taking into account also the prevalence of the mastitis among the data, 
were calculated in study I for S. aureus and for Staphylococcus spp. Positive predictive 
value (PPV) results in probability of the cow with a positive test result actually having an 
IMI. Negative predictive value (NPV) results in the probability of cow with a negative test 
result truly being free from IMI. 
4.9.2. Agreement between the diagnostic tests 
 
Agreement between BC and PCR in providing a positive IMI diagnosis was tested with 
Cohen`s Kappa (κ)-coefficient (I, IV). For these calculations, the BC and PCR results were 
converted into binary outcomes of positive IMI, yes (1) or no (0). κ-coefficient was also 
used in testing agreement between the two sampling techniques in detecting most common 






0.20 were characterized as slight, 0.21–0.40, fair, 0.41–0.60, moderate, 0.61–0.80, 
substantial, and in almost perfect agreement, 0.81–1 (McHugh, 2012).  
 
The effect of the sampling technique (conventional vs. cannula) on the proportion of 
different species found in the milk samples was tested with a Pearson's chi square test (III). 
The test was run only for those species for which there was at least one detection and with 
80% of 2 x 2 tables including over 5 detections (Dohoo et al., 2010). 
4.9.3. Comparison of the mean amounts of detected target pathogen 
DNA (II, III) 
 
The differences in the amount of detected target pathogen DNA by conventional and 
needle sampling techniques were tested separately for the most frequently detected species, 
C. bovis and Staphylococcus spp. (II). Samples were considered paired because the origin 
of the sample was the same quarter and only the sampling technique changed (II, III). 
Differences in means of recorded Ct values were calculated for the data separately for all 
three Ct cut-off values 34.0, 37.0 and 40.0 (II) using t-tests for paired samples. The results 
were significant if the p-value was <0.05. 
 
In study III, Student`s t-test for paired samples was used to compare the mean amounts 
of detected target pathogen DNA. Only samples containing less than three different species 
per sample were included in statistical calculations (III). The results were considered 
significant if the p-value was <0.05. 
4.9.4. Correlations (I, II, IV) 
 
Correlations between cfu/ml and genome copy number (gc)/ml were tested with 
Spearman`s rank correlation coefficient because the data were not normally distributed (I, 
IV). In study I, correlations between cfu/ml and gc/ml were calculated for Staphylococcus 
spp. and for S. aureus. Only samples which were positive with both methods, PCR and BC, 
were included (n=70 for S. aureus and n=75 for Staphylococcus spp.). The results were 
considered significant at p < 0.05. 
 
In study IV, correlations were calculated for the whole two-week period (0 – 336 h), but 
also for the acute phase of 0 – 36 h, the subsequent phase up to one week (45 – 168 h) and 
the second week, including sampling at 240 and 336 h PC. Correlations were calculated for 
samples originating from quarters infected with Staphylococcus spp. (i.e., both species 
together, n=280) and for S. simulans (n=120) and S. epidermidis (n=160) separately. 
Correlations between cfu/ml and gc/ml for both species were also shown separately for each 
individual cow. Due to the variation among cows, low statistical power due to small sample 







In study II, Spearman correlation was used to compare Ct values in paired samples taken 
with conventional aseptic sampling technique and with experimental needle technique. 
Correlations were calculated for the data with three different Ct cut-off values of 34.0, 37.0 
and 40.0. 
4.9.5. Statistical significance and used programs 
 
In all statistical analyses, p <0.05 was considered to represent the level of statistical 
significance (I-IV). Analyses were conducted with IBM SPSS Statistics for Windows, 
Version 20.0. (I), Version 21.0. (II) Armonk, NY: IBM Corp. and IMB SPSS Statistics 
Version 24.0. for Macintosh (IV) Armonk, NY: IBM Corp. Stata Version 11 (Stata 
Statistical Software: Release 11. College Station, TX: StataCorp LP.) was used in study III. 
4.9.6. Nomenclature 
 
Mastitis is defined as an inflammation of the parenchyma of the mammary gland (Zhao 
and Lacasse, 2008) and IMI as presence of pathogenic micro-organisms in the secretory 
tissue, the duct and tubules of the bovine mammary gland (International Dairy Federation, 
2011). Our definition throughout the thesis is that mastitis includes elevated indicator levels 
of inflammation and is caused by IMI. In study I, where the SCC status was not available, 
we assume that farmers sent samples only when SCC was high or there were some other 
clear indicators leading to suspected mastitis. In study II, CMT was performed for all tested 
quarters. Intentionally, fourteen quarters with CMT of one were included. In study III, all 
the cases were classified as mastitis where veterinary consultancy was needed. In study IV, 
we induced mastitis in every quarter. 
 
A result from multiplex real-time PCR assay is a Ct value. This indicates the number of 
cycles needed to detect the fluorescence of a target pathogen DNA. The Ct cut-off may be 
adjusted according to purpose. A PCR result was considered positive (PCR+) when target 
DNA was amplified from the sample with a Ct value under the set Ct cut-off value. PCR 
negative (PCR-) samples were defined as samples with no detected target pathogen DNA 
within the limits of the set cut-off value. The Ct cut-off for a positive PCR result and the 
spectrum of the used panel has been reported in each study separately. 
 
No agreed standard for contaminated sample is available in PCR. If the sample contained 






5 Results  
The results section comprises four parts. The first part is focused on comparison of 
culture and PCR results, including elimination of bacteria from infected quarters. The 
second part includes the effect of different sampling methods on PCR results. The third part 
presents the effect of Ct cut-off value on the results with respect to detected target 
pathogens, as well as the mean pathogen-specific Ct values. Results regarding inflammation 
indicators are presented in the last section.  
5.1.  Comparison of multiplex real-time PCR and 
conventional culture (I, IV) 
The proportion of samples positive for DNA of the target species (83%) in PCR was 
lower than proportion of samples positive in culture (85.3% 251/294) in natural IMI, in 
study I (Table 5). Most of the samples included only one or two different species (Table 5). 
No target DNA was detected in 17% of samples examined using PCR and 15% of the 
cultured samples yielded a no-growth result (Table 5). 
Table 5. Number and proportions of samples with different number of species detected with conventional 
culture (BC) or multiplex real-time PCR (PCR) from study I. Definition for a positive result in PCR was a sample 
with target DNA detected with a Ct value of £37.0 (PathoProofTM Complete-12 Kit). Definition of a positive BC 
result was ³100 cfu/ml. Samples were aseptic quarter milk samples originating from natural IMI, collected 
mainly by farmers. 
 
Study I 
Species detected per sample BC PCR 
 
n % n % 
0 43 14.6 50 17.0 
1 161 54.8 161 54.8 
2 52 17.7 59 20.1 
3* 30 10.2 18 6.1 
4* 6 2.0 5 1.7 
5* 2 0.7 1 0.3 
Total 294 100.0 294 100.0 
*Considered contaminated in the conventional bacterial culture 
 
 
In PCR results, the most prevalent species detected were Staphylococcus spp. (NAS) 
(n=113), S. aureus (n=79), Str. dysgalactiae (n=39) and Str. uberis (n=38) (Table 6). 
Staphylococcus spp. (NAS) were present as the only detected pathogen in 53% (60/113) and 
with one other pathogen in 32% of the samples. The second most prevalent pathogen, S. 
aureus, was present in 66% (52/79) as a single detection and in 24% (19/79) with one other 






Table 6. Total number of target pathogens from multiplex real-time PCR (I). The first column shows the total 
number of samples where the species was detected. The subsequent columns (1 - 5) indicate the total number 
of different species in the sample.  
 Study I 
 Total number of species detected by PCR 
  ntotal 1 2 3 4 5 
Corynebacterium bovis 28 4 17 5 2 0 
Enterococcus spp. 7 2 1 2 1 1 
Escherichia coli 17 7 6 3 1 0 
Klebsiella spp. 6 1 3 1 1 0 
Serratia marcescens 1 1 0 0 0 0 
Staphylococcus aureus 79 52 19 6 1 1 
Staphylococcus spp. (NAS) 113 60 36 12 5 0 
Streptococcus agalactiae 1 0 1 0 0 0 
Streptococcus dysgalactiae 39 14 13 9 2 1 
Streptococcus uberis 38 13 11 9 4 1 
Trueperella pyogenes/Peptoniphilus indolicus 29 7 11 7 3 1 
 
 
The most prevalent finding in BC results was coagulase negative staphylococci (CNS), 
followed by S. aureus (Table 7). Among all CNS positive samples (n=103), CNS was the 
only species found in 49.5% (51/103) and accompanied a high number of samples 
containing two or more pathogens (Table 7). In contrast, in 67.1% (49/73) of S. aureus 
positive samples, S. aureus was the only species found (Table 7).  
 
The proportion of BC samples with more than two species, which are considered 
contaminated according to the NMC interpretation guidelines (Middleton et al., 2017), was 
13% (38/294) with a detection limit of 100 cfu/ml (I) (Table 5). In PCR results, the 
corresponding figure was 8% (24/294), examined with a target panel of 11 pathogens and a 
Ct cut-off 37.0 (Table 5). Staphylococcus spp. were most commonly found in contaminated 
BC samples (61%, 23/38), followed by Corynebacterium spp., Aerococcus spp., Bacillus 
spp. and Str. dysgalactiae. The most prevalent pathogens in the multispecies samples tested 
with PCR were also Staphylococcus spp., followed by Str. uberis and T. pyogenes.  
 
Corynebacterium spp. other than C. bovis, Aerococcus spp. and Bacillus spp. 
represented the most frequent findings not included to the PCR test panel (Table 7). These 







Table 7. The culture results from 294 samples of (I). Definition of a positive culture was 100 cfu/ml. The first 
column shows the total number of samples where the species was detected. The subsequent columns (1 - 5) 
indicate the total number of different species in the sample. For example, Aerococcus spp. were detected in 20 
samples and 14 of those samples were contaminated. Species not detectable with PCR, e.g. not included in 
the PCR test panel (PathoProofTM Complete-12 Kit), are highlighted in light grey. 
  
  Number of different species in a sample, study I 
 ntotal
 1 2 3* 4* 5* 
Aerococcus spp. 20 3 3 11 3 0 
Bacillus spp. 12 2 1 7 2 0 
Chryseobacter spp. 3 0 0 0 2 1 
Coagulase negative staphylococci2 103 51 29 16 5 2 
Corynebacterium spp. 35 1 15 14 3 2 
Corynebacterium bovis 21 10 8 3 0 0 
Corynebacterium ulcerans 1 1 0 0 0 0 
Enterobacter spp. 1 0 0 1 0 0 
Enterococcus casseliflavus 1 1 0 0 0 0 
Enterococcus spp. 10 3 1 4 1 1 
Escherichia coli 11 7 2 1 1 0 
Gemella spp.? 1 0 0 0 1 0 
Globicatella spp. 2 0 0 2 0 0 
Klebsiella spp. 6 4 1 1 0 0 
Lactobacillus spp. 1 0 0 1 0 0 
Lactococcus spp. 6 1 3 0 1 1 
Leuconostoc spp.? 1 0 0 1 0 0 
Micrococcus spp. 1 0 0 1 0 0 
Moraxella spp. 1 0 1 0 0 0 
Raoultella spp.? 1 0 0 0 1 0 
Serratia marcescens 1 0 1 0 0 0 
Staphylococcus aureus 73 49 17 6 1 0 
Streptococcus agalactiae 1 1 0 0 0 0 
Streptococcus bovis 5 0 4 1 0 0 
Streptococcus dysgalactiae 27 11 7 7 2 0 
Streptococcus uberis 19 11 5 1 2 0 
Trueperella pyogenes 16 5 5 4 2 0 
Unidentified Gram-positive cocci 4 0 2 1 1 0 
Unidentified rod 2 0 0 2 0 0 
Yeast3 4 2 1 1 0 0 
ntotal Total number of findings of the species/group of species 
2 In PCR these are referred as Staphylococcus spp. i.e. non-aureus staphylococci 
3 Included in current PathoProofTM Complete-16 Kit 







Table 8. Cross-tabulation of results positive or negative in PCR and bacterial culture in study I. Ct cut-off value 
for a positive result was 37.0 (PathoProofTM Complete-12 Kit) and the detection limit for a bacterial culture was 
≥100 cfu/ml. 
 
PCR+ PCR- Total 
BC+ 224 27 251 
BC- 20 23 43 




About half (47%, 20/43) of the culture negative samples of study I were positive for 
PCR (Table 8), Staphylococcus spp. (NAS) representing the most prevalent species (Fig 4). 
Most of these PCR+/BC- results were detected in PCR with Ct values >32.0 (Fig 4), which 
indicate low bacterial counts according to the manufacturer. Str. dysgalactiae was an 
exception (Fig 4). 
 
Over 50% of the PCR negative samples showed microbial growth in culture (Table 8). 
One out of these 27 PCR-/BC+ samples was considered contaminated. In 48% (13/27) the 
cultured species was not included in the target panel of the PCR assay. The number of cfu/ml 
in PCR-negative samples varied between 100 and ³10 000 cfu/ml (mean 1 281 cfu/ml, 
median 200 cfu/ml). Staphylococcus spp. were cultured most often from PCR- samples 









Fig 4. Species detected with PCR (n=20) from milk samples with no growth in the conventional bacteriological 
culture (43/294) (I). Ct cut-off for a positive PCR detection was 37.0. Each vertical line represents a single 
culture negative sample. 
 
 
Fig 5. Cultured species and their bacterial counts (n=27) for quarter milk samples negative for any target-DNA 
in multiplex real-time PCR assay (50/294), study I. Detection limit for a positive culture result was ≥100 cfu/ml. 






5.1.1.  Comparison of the BC and PCR results in experimental CNS 
challenge  
Only two different coagulase negative staphylococcal species were used in the 
experimental challenge (IV). The PCR panel was the same as in study I, which does not 
differentiate these two species, but presents the result as Staphylococcus spp. A total of 280 
samples were examined, 160 originating from quarters infected with S. epidermidis and 120 
from quarters infected with S. simulans. In BC, a total of 80% (224/280) were positive for 
CNS and 90% (253/280) of the samples positive for Staphylococcus spp. in PCR (Ct cut-
off 37.0) (Table 9). Of the S. epidermidis infected quarters, 75% (120/160) were positive in 
BC and 88% (140/160) in PCR (Ct cut-off 37.0). For S. simulans the corresponding figures 
were 87% (104/120) and 93% (112/120) (Table 9). 
Table 9. Number of detections in multiplex real-time PCR (PCR) and bacterial culture (BC) from the 
Staphylococcus spp. experimentally infected quarters. The results are presented with two different Ct cut-off 
values, 37.0 and 34.0. Agreement between PCR and BC is reported with Cohen`s Kappa. All results are 
presented for the whole two-week study period (0 - 336 h) and separately for the first 36 h, the subsequent 45 
- 168 h and 240 - 336 h post challenge (PC). All Cohen`s Kappa results were statistically significant (p < 0.05), 
except for two results marked in the table. 
 
    Ct 
37.0 
        Ct 
34.0 
        
  




PCR+ PCR- PCR- PCR+ Kappa PCR
+ 
PCR- PCR- PCR+ Kappa 
0 - 336 Staphylococcus 
spp. 
218 6 21 35 0.42 200 24 32 24 0.46 
 
S. epidermidis 114 6 14 26 0.36 101 19 24 16 0.43 
 
S. simulans 103 1 7 9 0.54 100 4 8 8 0.49 
            
            
0 - 36 Staphylococcus 
spp. 
94 2 14 2 0.85 91 5 14 2 0.76 
 
S. epidermidis 55 1 8 0 0.93 53 3 8 0 0.82 
 
S. simulans 39 1 6 2 0.76 38 2 6 2 0.70 
            
45 - 168 Staphylococcus 
spp. 
103 4 3 30 0.072 91 16 14 19 0.28 
 
S. epidermidis 55 4 3 18 0.092 46 13 10 11 0.25 
 
S. simulans 48 0 0 12 - 45 3 4 8 0.32 
            
240 - 336 Staphylococcus 
spp. 
20 1 4 3 0.58 18 3 4 3 0.43 
 
S. epidermidis 10 1 3 2 0.54 8 3 3 2 0.312 
  S. simulans 10 0 1 1 0.63 10 0 1 1 0.63 
1Post challenge 






Of the 56/280 culture negative samples in study IV, 63% (35/56, Ct 37.0) and 43% 
(24/56, Ct 34.0) were positive in PCR for Staphylococcus spp. (Table 9). In results 
originating from quarters infected with S. epidermidis, a total of 14% (40/280) samples were 
negative in BC. Of these BC negative S. epidermidis samples, PCR detected DNA of 
Staphylococcus spp. from 65% (26/40, Ct 37.0) and 40% (16/40, Ct 34.0). From BC 
negative S. simulans samples (13%, 16/120), 56% (9/16, Ct 37.0) and 50% (8/16, Ct 34.0) 
gave a positive Staphylococcus spp. detection in PCR (Table 9). The majority of these BC-
/PCR+ detections occurred between 50 – 150 h post challenge with recorded Ct values of 
>30.0. SCC of those quarters varied between 5 000 and 10 x 106 cells/ml (mean 2.0 x 106, 
median 519 000 cells/ml of milk) (IV).  
Only 3% (6/224) of the samples where the staphylococcus strains were detected in BC 
were PCR- negative for Staphylococcus spp. with a Ct cut-off of 37.0 Bacterial counts (BC) 
in these six samples varied from 20 to 1 090 cfu/ml (median 95 cfu/ml). With the lower Ct 
cut-off value of 34.0, 10% (23/224) of the culture positive samples were negative in PCR, 
with bacterial counts in BC ranging between 10 and 1 870 cfu/ml (median 140 cfu/ml).  
5.1.2. Sensitivity (Se), specificity (Sp) and predictive values (I) 
Relative Se and Sp of the PCR assay for detecting S. aureus or Staphylococcus spp. were 
calculated assessing the culture as the reference (gold standard). Se and Sp for S. aureus 
was 97.0% and 95.8%. Se and Sp for PCR detecting Staphylococcus spp. was 86.7% and 
75.4%. Positive predictive value for S. aureus was 88.9% and negative predictive value 
98.9%. For Staphylococcus spp. the corresponding figures were 42.9% and 96.4%. 
5.1.3. Agreement between BC and PCR in detecting pathogens (I, IV) 
 
In study I with natural IMI (n=294) and with a BC detection limit of 100 cfu/ml, S. 
aureus was cultured only once from a PCR negative sample (Ct cut-off 37.0) and detected 
with PCR from three culture negative samples. The agreement (κ-coefficient) between the 
two diagnostic tests in detecting S. aureus was 0.90 (p < 0.05), indicating almost perfect 
agreement (I). With Staphylococcus spp. (NAS) in natural IMI and BC detection limit of 
500 cfu/ml, the agreement between the tests was 0.44 (p < 0.05), considered moderate 
agreement (I).  
 
In the experimental challenge study IV, the agreement between the tests detecting 
Staphylococcus spp. was almost perfect (κ = 0.85) for the first 36 h after the challenge when 
PCR results were assessed with Ct cut-off 37.0 and substantial (κ = 0.76) with cut-off 34.0 
(IV). For the whole 336 h study period, a moderate agreement was achieved (BC detection 
limit 10 cfu/ml) (IV). Agreement between BC and PCR for the whole 336 h was better for 
S. simulans than for S. epidermidis and the two tests agreed better with Ct cut-off 37.0 than 






5.1.4. Correlation between genome copy numbers from PCR and colony 
forming units from BC (I, IV) 
Correlation between gc/ml and cfu/ml for S. aureus was 0.68 (p < 0.05, I). From fourteen 
samples with PCR indicating low amount (Ct >30.1) of S. aureus DNA according to 
manufacturers` interpretation guideline, over 2 000 cfu/ml were cultured. In five of those 
samples the S. aureus counts exceeded 10 000 cfu/ml (I). Correlation between gc/ml and 
cfu/ml in natural Staphylococcus spp. IMI was only moderate to poor (0.47, p < 0.05, I). 
Figures 6 and 7 show all the results for S. aureus (n=81) (Fig 6.) and Staphylococcus spp. 
(Fig 7) which were positive with BC, PCR or with both. To see the scatterplot based on the 





Fig 6. Scatterplot of all samples positive for S. aureus with either PCR (gc/ml) or BC (cfu/ml) or both from study 
I (n=81). Bacteria counts exceeding 100 cfu on agar plates were recorded as 100, which explains the 
accumulation of the S. aureus on the high Y-axis. Ct cut-off for a positive PCR result was 37.0 and a cut-off for 








Fig 7. Scatterplot of all samples positive for Staphylococcus spp. (non-aureus detections) with either PCR 
(gc/ml) or BC (cfu/ml) or both from study I (n=121). Ct cut-off for a positive PCR result was 37.0 and a cut-off 
for considering a sample positive for Staphylococcus spp. in BC was 500 cfu/ml. 
 
 
In the experimental study (IV), correlation between cfu/ml and gc/ml for Staphylococcus 
spp. for the whole 336 h period was 0.55. For the first 36 h, the subsequent 45 – 168 h and 
240 – 336 h PC the corresponding figures were 0.68, 0.44 and 0.46. Correlation between 
cfu/ml and gc/ml varied according to the species and the cow. For S. epidermidis, the 
correlation coefficient was 0.60 (Fig 8, Panel A) and for S. simulans 0.55 (Fig 8, Panel B). 
In S. epidermidis infected quarters (Cows 1 - 8) correlations were 0.80, 0.35, 0.70, 0.59, 
0.70, 0.81, 0.31 and 0.69. For quarters infected with S. simulans (Cows 1 - 2 and 4 - 8) 











Fig 8. Scatterplot of colony forming units (cfu/ml) from culture results for S. epidermidis (n=160, panel A) and 
S. simulans (n=120, panel B) and genome copy (gc/ml) results from PCR for Staphylococcus spp. (non-aureus 
staphylococci) in the experimental study IV. The high bacterial counts in BC were enabled by counting the 






5.1.5. Elimination of bacteria according to PCR and BC (IV) 
Elimination of experimentally induced bacteria from a mammary quarter was followed 
with BC and PCR in study IV. Bacterial count curves behaved similarly according to both 
diagnostic methods during the acute phase, i.e. for the first 36 h. In the subsequent phase, 
45 – 168 h, the number of gc/ml increased again and exceeded the highest numbers recorded 
during the acute phase. Colony counts from culture also increased after the first 36 h, but 
never reached the numbers recorded during the acute phase (Fig 9). Bacterial counts with 
both methods, BC and PCR, were lower in samples defined as cured at the end of the study 
period compared with those defined as persistent (IV) (Fig 9).   
 
 
Fig 9. Mean bacterial counts from conventional culture (cfu/ml), genome copy numbers (gc/ml) from multiplex 
real-time PCR and milk SCC (cells/ml) in mammary quarters (n=14) experimentally infected with 
Staphylococcus spp.  during the two-week (336 h) study period presented on a logarithmic scale. Vertical lines 
show time points of milk sampling. Acute phase of the infection was defined as the first 36 h post challenge, 




Four quarters were defined cured at the end of the study period according to BC results. 
Only one of those quarters was defined as being negative in PCR (Fig 10, Panel a). Negative 
culture samples, indicating bacterial cure of IMI, were seen in BC several days before 
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Fig 10.  Panels A - D show elimination of Staphylococcus spp. from individual quarters with bacteriological cure 
during the two-week study period (336 h). Definition for cure was a negative culture result (<10 cfu/ml) in the 
last sampling at 336 h post challenge. Bacterial counts were assessed with conventional bacterial culture 
(cfu/ml) and with multiplex real-time PCR (genome copies; gc/ml). Three of the quarters were infected with S. 
epidermidis (Panels A - C) and one with S. simulans (Panel D). Milk SCC of the quarters is also shown. Vertical 







5.2. The effect of milk sampling technique on multiplex real-
time PCR results (II, III) 
5.2.1. The effect of sampling method on the number of species per 
sample 
The number of PCR negative samples was higher in samples taken with experimental 
techniques than using conventional aseptic sampling (p < 0.05, Table 10). The number of 
species detected per sample was significantly lower in samples taken with cannula or needle 
compared with the conventional samples (p < 0.05, Table 10). From samples collected with 
the experimental needle method, 69.9%, 68.1% and 46.9% of samples yielded a positive 
DNA finding with Ct cut-off values of 40.0, 37.0 and 34.0 (II). Of the samples taken with a 
cannula, 74.5% were positive with the routine cut-off of 37.0 (III) (Table 10). 
 
The number of multispecies samples among conventionally taken samples with a Ct cut-
off of 37.0 was 9% (10/113) in study II and 21% (31/149) in study III (Table 10). In samples 
taken by needle only 1% (1/113) included more than two different pathogens. In samples 
taken with a cannula, 5% (8/149) included more than two different species.  
 
In multispecies samples obtained with conventional milk sampling, Staphylococcus spp. 
and C. bovis were present in all samples with Ct cut-offs of 40.0 and 37.0 (II). These two 
represented also the most prevalent findings for multispecies, conventionally taken samples 
of study III.  
Table 10. Number of samples containing 0 - 5 different target species per sample in studies II and III, where 
experimental needle and cannula sampling methods were compared with the conventional aseptic milk 
sampling techniques. Results of study II are presented with three different Ct cut-offs, 40.0, 37.0 and 34.0, and 
results of study III with a Ct cut-off of 37.0. Total number of sampled quarters was 113 in study II and 149 in 
study III. All samples presented here were examined with PathoProofTM Complete-16 Kit. N1 is the total number 
of different target pathogens in a sample. 
 
Study II,  
Conventional 






N1 Ct 40.0 Ct 37.0 Ct 34.0 Ct 40.0 Ct 37.0 Ct 34.0 Ct 37.0 Ct 37.0 
0 26 26 45 34 36 60 27 38 
1 31 37 40 55 61 47 59 74 
2 40 40 25 21 15 6 32 29 
3 12 9 3 3 1 0 21 4 
4 2 1 0 0 0 0 10 4 
5 2 0 0 0 0 0 0 0 






5.2.2. The effect of sampling method on the detected bacterial species 
 
The most prevalent pathogens in samples taken with the conventional aseptic milk 
sampling technique in study II were Staphylococcus spp. and C. bovis, followed by yeasts 
and Str. uberis (II). With needle sampling, the most frequent pathogens were C. bovis, 
Staphylococcus spp., yeasts and Str. uberis (II).  
 
The number of positive Staphylococcus spp. detections in conventionally taken milk 
samples were over twice as high as in samples obtained with the needle method (p < 0.05, 
II) (Fig 11). For pathogens other than Staphylococcus spp. and C. bovis, the number of 





Fig 11. Number of samples positive for Corynebacterium bovis and Staphylococcus spp. (non-aureus 
staphylococci) taken using the conventional milk sampling technique and using the experimental needle 
technique. Results are presented for three different Cycle threshold (Ct) cut-offs (40.0, 37.0, and 34.0). 
 
In study III, the most prevalent species in conventionally taken samples were 
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Samples taken with cannula most often included DNA from Staphylococcus spp., C. bovis, 
S. aureus and yeasts (Table 13). 
 
Staphylococcus spp., yeasts, T. pyogenes/P. indolicus and Str. dysgalactiae were 
detected more often in conventional samples compared with cannula sampling (III, p < 
0.05). The amount of amplified DNA for Staphylococcus spp., S. aureus, C. bovis, T. 
pyogenes/P. indolicus and Str. dysgalactiae was also significantly higher in results from 
conventionally taken samples compared with cannula samples (III, p < 0.05).  
 
The sampling technique did not affect the number of samples positive for C. bovis or for 
S. aureus DNA, but the amount of DNA of these two pathogens was significantly higher in 
conventionally taken samples than in cannula samples (III, p < 0.05).  
 
5.3. Cycle threshold (Ct) values and the effect of different cut-
offs on the PCR results (II-III) 
5.3.1.  Effect of different Ct cut-off values on the PCR results (II, IV) 
The effect of alternative Ct cut-off values on PCR results were observed in studies II 
and IV. Ct cut-off values had a significant effect on the number of positive samples in both 
studies (p < 0.05). In conventionally taken samples, the percentage of the samples positive 
for target-DNA was 77% with Ct cut-offs of 40.0 and 37.0 and 60.2% with a cut-off of 34.0 
(II). Lowering the Ct cut-off from 40.0 to 34.0 decreased the number of positive 
Staphylococcus spp. results by over 50% in study II with both sampling methods.  
 
In study II, the number of negative samples for target DNA in conventionally sampled 
quarters doubled when the Ct value was lowered from 40.0 and 37.0 to 34.0 (Table 10). The 
number of PCR-negative samples taken with the needle method increased from 30% (Ct 
40.0) and 32% (Ct 37.0) to 53% with Ct cut-off 34.0 (Table 10). 
 
Proportion of samples taken with conventional methods including more than two 
different species was 14.2% with a Ct cut-off of 40.0, 9% with Ct of 37.0 and 2.7% with Ct 
cut-off of 34.0. In samples taken by needle, the proportion of samples with more than two 
target species was 3% with Ct cut-offs of 40.0 and 37.0 and 1% with a Ct cut-off of 34.0 
(Table 10). 
 
In study II, the most substantial change (p < 0.05) at species level was seen with the 
proportion of Staphylococcus spp. when results were considered with a Ct cut-off of 34.0 
instead of 37.0 (Fig 11). The number of major pathogen found was too small for statistical 
calculations, but in descriptive data the change of Ct value from 37.0 to 34.0 did not seem 






Table 11. The number of targeted DNA results from quarter milk samples examined with multiplex real-time 
PCR (PathoProofTM Complete-16 Kit). Quarters were sampled using an aseptic conventional milk sampling 
technique and an experimental needle sampling technique and observed with three different Ct cut-offs: 40.0, 
37.0 and 34.0 (II). All samples were negative for Klebsiella spp., Serratia marcescens and Mycoplasma bovis. 
 
Conventional sampling Needle sampling 
Target Ct 40.0  Ct 37.0 Ct 34.0 Ct 40.0 Ct 37.0 Ct 34.0 
blaZ 13 10 5 12 12 5 
Corynebacterium bovis 53 52 50 47 43 27 
Enterococcus spp. 4 4 3 4 3 3 
Escherichia coli 1 0 0 1 0 0 
Mycoplasma spp. 1 1 0 0 0 0 
Prototheca 1 1 1 2 1 1 
Staphylococcus aureus 4 4 4 4 4 4 
Staphylococcus spp. 66 62 26 27 23 11 
Streptococcus agalactiae 0 0 0 1 1 0 
Streptococcus dysgalactiae 3 3 2 2 2 2 
Streptococcus uberis 12 12 11 8 8 8 
Trueperella pyogenes/ Peptoniphilus indolicus 3 1 1 1 1 1 
Yeast 17 9 1 9 8 2 
Number of negative samples 26 26 45 34 36 60 




In the experimental challenge (IV), 94% (264/280), 90% (252/280) and 80% (224/280) 
of the samples were positive for Staphylococcus spp. DNA with Ct cut-offs 40.0, 37.0 and 
34.0.  
 
The only quarter defined as cured with PCR (negative in the last sampling) was negative 
at 336 h PC with Ct 40.0, but with a Ct cut-off 37.0 this IMI would have been considered 
cured at 240 h PC and even at 126 h PC if a tighter cut-off (34.0) was used (Table 12). 
Observing the results with a cut-off of 37.0, a total of six quarters had one or several negative 
PCR results during the sampling period. When using the lower cut-off of 34.0, some samples 
of nine different quarters would have yielded negative results during study periods (Table 
12). Of the total number of culture negative samples, 63% (Ct 37.0) and 43% (34.0) yielded 
positive PCR results for Staphylococcus spp., with most of these samples occurring between 
45 – 336 h PC. Bacterial counts varied considerable compared with genome copy numbers 
from PCR. Some of the sample culture negative samples gave low Ct values in PCR, 







Table 12. Ct values of the quarters experimentally infected with S. epidermidis (n=8) and S. simulans (n=6). A 
quarter was defined cured in bacterial culture if it was negative (<10 cfu/ml) in the final sampling at 336 h post 
challenge. No DNA was detected in negative (neg) multiplex real-time PCR results with highest possible Ct cut-
off (40.0). Sampling results highlighted in dark grey were negative when considered at a PCR Ct cut-off of 37.0. 
Additionally, the negative results with a Ct cut-off of 34.0 are highlighted with lighter grey. PC = hours post 
challenge. 
 































0 neg neg neg neg neg neg 16.6 neg neg neg neg neg neg neg 
4 24.5 25.5 neg 33.7 30.1 25.5 27.9 29.3 29.8 26.5 18.0 19.1 17.9 18.6 
6 25.6 26.3 37.5 27.0 27.1 23.8 27.3 27.3 27.0 25.8 18.4 17.9 17.7 17.8 
12 26.4 27.4 31.8 32.0 28.9 28.2 32.6 35.0 26.7 28.4 24.1 22.6 29.2 20.5 
21 27.4 27.8 31.7 29.3 30.1 29.2 32.4 30.8 30.3 29.7 29.0 28.4 29.6 30.2 
27 30.7 30.7 39.5 31.5 31.6 29.9 33.5 31.8 29.7 27.3 29.7 30.2 26.8 28.3 
30 26.9 30.9 33.9 30.4 29.2 29.7 33.1 32.9 31.8 29.9 23.1 32.9 31.5 29.6 
36 29.0 30.8 33.6 31.3 30.5 31.3 33.9 34.3 30.7 30.2 30.9 31.1 34.2 31.7 
45 28.4 33.9 37.2 30.6 30.8 32.4 22.6 29.8 30.1 30.0 20.5 30.1 33.1 26.7 
54 32.0 32.2 35.9 29.4 30.3 33.8 33.7 38.9 32.7 30.3 17.4 29.5 25.8 33.0 
69 29.3 33.3 35.4 31.2 27.4 33.9 34.0 38.7 32.3 27.0 19.6 27.0 27.1 27.7 
78 30.3 33.7 39.0 29.8 29.1 34.4 33.0 30.5 32.5 28.8 19.5 27.1 33.0 22.1 
93 31.7 31.4 35.2 29.0 28.3 35.0 31.6 29.1 32.5 25.9 17.5 26.9 20.9 17.9 
102 32.0 35.6 34.8 32.5 28.1 34.4 34.3 32.2 30.8 29.2 17.9 20.1 20.2 17.8 
117 33.1 35.6 33.0 31.6 30.1 36.7 36.9 27.9 34.7 29.6 18.0 22.9 17.1 16.8 
126 34.1 31.3 38.4 31.2 30.5 35.0 38.8 36.8 34.9 30.1 17.8 18.5 21.7 18.1 
141 37.8 29.6 34.2 30.4 29.5 37.0 26.9 31.6 29.3 29.7 17.9 34.7 16.8 16.6 
168 36.3 33.3 34.4 29.5 25.4 30.2 18.0 27.4 28.8 25.3 18.0 35.6 17.9 16.6 
240 40.0 34.4 29.6 29.0 18.3 38.7 21.9 30.4 33.8 23.3 17.7 38.4 17.9 17.5 






















1Defined cured in culture i.e. 0 cfu/ml in last sampling      
 
5.3.2. Ct values 
 
Species present in samples with the highest Ct values in conventionally sampled results 
were yeasts and Staphylococcus spp. (I-III) (Table 13), indicating the lowest amounts of 
detected DNA. Species present with the lowest average Ct values were Str. dysgalactiae, S. 
aureus and S. uberis, indicating the highest amounts of detected DNA (Table 13).  
 
In results originating from experimentally sampled quarters, the results were similar, 
yeasts and Staphylococcus spp. representing the highest average Ct values, followed by C. 
bovis (Table 10). Str. dysgalactiae, Str. uberis and S. aureus were present with the lowest 








Table 13. Number of positive samples (N) and Ct values (median, mean, SD) of targeted pathogens from 
studies I-III. All the samples originated from natural IMI and were sampled using an aseptic conventional milk 
sampling technique. Samples from study I were examined with PathoProofTM Complete-12 Kit and samples 
from studies II and III with Complete-16 Kit, which included additional targets for Mycoplasma spp., M. bovis, 
Prototheca spp. and yeasts. All the results are presented with Ct cut-off 37.0. 
 Study I  Study II  Study III 
  N MEDIAN MEAN SD N MEDIAN MEAN SD N MEDIAN MEAN SD 
BlaZ - - - - 10 33,8 31,8 5,1 27 33,0 32,2 3,4 
Corynebacterium bovis 28 32,3 32,3 2,9 52 28,9 29,2 2,1 26 31,5 30,7 2,6 
Enterococcus spp. 7 30,7 31,1 3,7 4 32,0 32,3 3,3 5 30,0 31,3 4,3 
Escherichia coli 17 29,2 30,6 4,8 0 - - - 14 27,6 28,7 5,2 
Klebsiella spp. 6 33,9 28,6 9,5 0 - - - 5 34,4 31,2 8,4 
Mycoplasma bovis 0 - - - 0 - - - 0 - - - 
Mycoplasma spp. 0 - - - 1 36,5 36,5 - 0 - - - 
Prototheca 0 - - - 1 25,7 25,7 - 2 35,5 35,5 2,0 
Serratia marcescens 1 35,0 35,0 - 0 - - - 0 - - - 
Staphylococcus aureus 77 29,7 28,8 4,4 4 27,0 27,2 1,3 19 28,1 27,3 5,8 
Staphylococcus spp. 114 33,1 32,9 3,1 62 34,7 33,5 3,3 69 32,0 31,4 3,9 
Streptococcus agalactiae 1 22,7 22,7 - 0 - - - 0 - - - 
Streptococcus dysgalactiae 39 28,1 27,9 4,2 3 23,6 25,5 9,4 23 32,2 30,4 5,7 
Streptococcus uberis 38 29,2 29,3 5,2 12 30,4 30,1 3,4 18 29,9 29,9 5,0 
Trueperella pyogenes/ 
 Peptoniphilus indolicus 
29 31,2 30,1 6,6 1 21,9 21,9 - 17 35,1 31,4 6,2 
Yeast 0 - - - 9 36,2 35,5 2,1 35 34,4 33,8 2,4 
 
Table 14. Number of positive samples (N) and Ct values (median, mean and SD) of the detected target 
pathogens and blaZ (PathoProofTM Complete-16 Kit) from milk samples from studies II and III. All the samples 
originated from natural IMI. Samples were taken using experimental needle (II) or cannula (III) techniques. All 
the results have been presented here with a Ct cut-off of 37.0.  
 Needle, study II, n=113 Cannula, study III, n=149  
  N MEDIAN MEAN SD N MEDIAN MEAN SD 
BlaZ 12 35,2 32,9 4,0 19 34,8 33,0 3,4 
Corynebacterium bovis 43 33,1 33,0 2,2 23 33,6 33,0 2,6 
Enterococcus spp. 0 - - - 5 32,7 32,7 3,9 
Escherichia coli 3 30,4 30,0 1,1 9 26,1 26,3 2,9 
Klebsiella spp. 0 - - - 3 33,1 27,9 9,7 
Mycoplasma bovis 0 - - - 0 - - - 
Mycoplasma spp. 0 - - - 1 36,4 36,4 - 
Prototheca 1 26,8 26,8 - 0 - - - 
Serratia marcescens 0 - - - 0 - - - 
Staphylococcus aureus 4 28,5 28,5 1,2 17 31,0 30,0 4,8 
Staphylococcus spp. 23 35,1 32,7 4,3 56 33,6 32,9 3,0 






Streptococcus dysgalactiae 2 23,5 23,5 1,6 11 27,9 28,3 4,7 
Streptococcus uberis 8 29,2 27,9 4,1 14 32,5 31,6 5,4 
Trueperella pyogenes/ 
Peptoniphilus indolicus 1 23,8 23,8 - 6 30,0 29,7 6,2 
Yeast 8 35,4 34,4 2,5 15 35,0 34,3 2,2 
 
5.4. Indicators of inflammation (I-IV) 
5.4.1. NAGase (I) 
 
Mean Nagase activity for the samples in study I was 5.79 pmol 4-MU/min/µl (I), and 
1.04 pmol 4-MU/min/µl is considered the upper limit for normal milk (Hovinen et al., 2016). 
According to the NAGase activities, 246/294 (83.7%) of the samples originated from 
mastitic quarters.  
5.4.2. SCC (II, III, IV) 
 
Mean SCC for 109 (of the 113 samples) in study II was 1 748 x 103 cells/ml with a range	
from	32	to	5	722	x 103	cells/ml	and	a	median	of 901 x 103 cells/ml of milk. The remaining 4 
of the 113 clinical mastitis samples gave an error in the DCC device because of clotting of 
the sample and were not included. SCC was over 1 000 x 103 cells/ml in 49% (53/109) of 
the samples and below 100 x 103 cells/ml in 15% (16/109, II) of the samples. In Fig. 12, 
panel A, the samples form two clusters, because the samples are arranged according to their 
original sampling numbers, the results on left cluster is from herd 1 and the other cluster 
includes the results of the herd 2 (Fig 12, panel A). 
 
In study III, 59/149 (39.6%) milk samples were collected from quarters with clinical 
mastitis, but milk SCC could not be determined from 22/59 clinical mastitis samples 
because of flakes and clots in the milk. Thus, a total of 37/149 (24.8%) samples were 
included in the analysis. The mean SCC was 3 239 x 103 cells/ml (SD 1 705 x 103 cells/ml) 
and median 3 198 x 103 cells/ml. A total of 90/149 (60.4%) samples originated from quarters 
with subclinical mastitis with mean SCC of 2 043 x 103 cells/ml (SD 1 432 x 103 cells/ml) 
and median 2 071 x 103 cells/ml (Fig 12, panel B.)  
 
In study IV, SCC was measured at every sampling point resulting a total of fourteen 
SCC recordings for each quarter (Fig 12, panel C). SCC exceeded 100 x 103 cells/ml in all 
infected quarters during the study period. Levels of SCC reaching the upper detection limit 
(10 000 x 103 cells/ml) were recorded between 12 - 45 h post challenge (PC), except for one 






epidermidis and three quarters infected with S. simulans had decreased to under < 100 x 103 









































Fig 12. SCC for studies II (panel A), III (panel B) and IV (panel C) are presented. SCC from study II are sorted 
according to sampling number, which leads to two different clusters seen on the figure (panel A). Results from 
study III (panel B) are randomly allocated, but SCC of quarters diagnosed with subclinical mastitis and clinical 
mastitis are presented separately. SCC from study IV is sorted according to the sampling time points resulting 














































6.1. Comparison of multiplex real-time PCR and conventional 
culture  
Bacterial culture has been the method of choice in bovine mastitis diagnostics, but the 
existence and usefulness of DNA-based molecular identification protocols have recently 
been acknowledged (Middleton et al., 2017). Differences between multiplex real-time PCR 
and BC as diagnostic tests are substantial. The basic principle in BC is to grow living 
microbes from the sample in favourable conditions, evaluate bacterial abundance by 
assessing the extent of bacterial colonies if possible, and identify the organisms by 
evaluating their phenotypic features. In multiplex real-time PCR, the principle is to extract 
all DNA from the sample, amplify pre-determined target sequences from the microbial 
genomes present and evaluate the bacterial counts based on detection limits (Ct values) or 
numbers of genome copies. DNA is amplified in PCR irrespective of the viability or original 
fitness of the microbes. When a new diagnostic method becomes available it must be 
compared with the standard method in order to understand it and put it into context for 
routine use. The methodology in culture and the PCR test panels play important roles when 
comparing BC and PCR results and must be taken into account when literature is evaluated. 
 
In the first study included in this thesis we studied quarter milk samples taken from 
naturally occurring mastitis cases. In contrast with studies published to date, the proportion 
of microbiologically positive samples was lower when examined with PCR (83%) than with 
traditional culture (85%, I). In previous studies, milk samples originating from clinical 
(Koskinen et al., 2010; Keane et al., 2013) or subclinical (Koskinen et al., 2010; Spittel and 
Hoedemaker, 2012) spontaneous naturally occurring mastitis were more often positive for 
udder pathogens when tested with PCR than with BC. The discrepancy between the results 
is likely explained by the in-depth culture method we used, where each morphologically 
different pathogen on agar plates was enumerated and identified. This level of species 
identification in BC needs high levels of expertise and advanced culture protocols and agars 
for rare pathogens, and results in increased costs. In routine mastitis laboratories, basic 
identification schemes have been considered sufficient (Middleton et al., 2017). The PCR 
test panel used in study I and in the other studies referred to, included only 11 target 
pathogens (PathoProofTM Complete-12 Kit), which raised concern as to whether the 
spectrum of the panel was sufficient for routine, quarter-based mastitis diagnostics.  
 
In 26% (77/294) of the samples from study I, species not included in the PCR test panel 
were cultured with a detection limit of 100 cfu/ml. The most prevalent species not detectable 
with PCR were Corynebacterium spp. other than C. bovis, Aerococcus spp. and Bacillus 
spp., all very uncommon mastitis-causing pathogens, at least in the latest culture-based 
survey carried out in Finland (Pitkälä et al., 2004). If the detection limit for BC was 
increased to 500 cfu/ml, the proportion of samples with pathogens not detectable by the 






caused by yeasts, which belong to the current test panel (PathoProofTM Complete-16 Kit). 
In a German study, only 1% (7/681) of quarter milk samples from subclinical mastitis cases 
included species outside the target panel: one Pseudomonas spp. and six yeasts (Spittel and 
Hoedemaker, 2012). Keane et al. (2013) concluded that the PCR assay targeted all the major 
pathogens associated with clinical mastitis in Ireland, reflecting well the pathogen profile in 
the Irish population defined previously using culture techniques. The same PCR assay was 
used in both of these studies. According to our results and the associated literature it seems 
that the current PCR panel in use, with additional oligos for Mycoplasma spp., Mycoplasma 
bovis, Prototheca spp. and yeasts (PathoProofTM Complete-16 Kit), is sufficient for 
diagnosing bovine IMI from quarter milk samples.  
  
Culture-negative samples from cases of clinical and subclinical mastitis have been a 
common finding in BC, causing frustration to veterinarians and dairy producers. Using a 
PCR assay, many of these samples have contained DNA of target pathogens. Proportions of 
target-DNA positive results from culture-negative samples (BC-/PCR+) have varied from 
43% (Taponen et al., 2009) and 47% (Bexiga et al. 2011a) up to 79% (Keane et al., 2013). 
Our results from naturally occurring IMI (I) were similar: 47% of the culture negative 
samples were positive for target-DNA in PCR. In our study, the detected amount of DNA 
in all these samples was low, which may indicate contamination or already clearing 
infection (I). Our results agree with those of Spittel and Hoedemaker (2012), who reported 
that amount of DNA was usually high if the species was detected in the sample with both 
diagnostic methods, BC and PCR. For example, for S. aureus, the mean Ct was 29.4 in 
BC+/PCR+ samples compared with 34.0 in PCR+/BC- samples (Spittel and Hoedemaker, 
2012), which indicates almost 14 times as high amounts of DNA in PCR+/BC+ samples as 
in PCR+/BC. In our studies (I-III), S. aureus was present with mean Ct values ranging from 
27.7 to 28.8 (Table 13), but in culture negative samples in study I, the lowest recorded value 
was 34.1 (Fig 4). Spittel and Hoedemaker (2012) also presented similar findings with 
Staphylococcus spp. and for Str. uberis (Spittel and Hoedemaker, 2012). 
 
Culture-positive results from PCR-negative samples (BC+/PCR-) also occur. This is 
possible if the organism isolated is not included in the target panel and thus cannot be 
detected with PCR. In our study I, 27 samples out of 50 PCR- samples (9.2%) were positive 
in culture. In half of those samples, a species outside of the target panel of PCR was detected. 
Our numbers were higher compared with previously published papers, with the proportion 
of BC+/PCR- samples varying between 2% – 7% (Keane et al., 2013; Koskinen et al., 2010; 
Spittel and Hoedemaker, 2012). The most prevalent species cultured from PCR-negative 
samples were Staphylococcus spp., but only with low bacterial counts, ranging from 100 to 
500 cfu/ml. Excessive handling and transportation of the samples in study I may have 
subjected our samples to cross-contamination, but it does not fully explain the results. 
Explanation for this could be heterogeneous distribution of microbes in milk samples or 
poor mixing of the sample, which is doubtful in a standardized reference laboratory. Oligos 
for commercial PCR assays have been designed specifically to include most common 
mastitis-causing strains of each target species. It is possible that these Staphylococcus spp. 






Staphylococcus spp. (NAS) represent a group that stood out on several occasions 
throughout the work embodied in this thesis. In study I we concluded that PCR was a reliable 
tool for identification of mastitis-causing S. aureus, but it did not perform as reliably with 
Staphylococcus spp. (NAS), using BC as the reference method. The agreement between BC 
and PCR for detecting S. aureus in study I was 0.90 and for NAS 0.44 (p < 0.05). Similar 
observations were published previously (Spittel and Hoedemaker, 2012). In study IV, where 
only two CNS strains were included, the agreement between BC and PCR was dependent 
on the timing of the sampling. If the sample was taken during the acute phase of IMI, the 
agreement between BC and PCR was almost perfect (kappa = 0.85), but decreased to a 
moderate level as time passed in relation to the challenge. In general, the low agreement 
between BC and PCR in detecting NAS may be due to the variety of species within the 
group, with no routine species identification in BC nor in PCR. In study II we showed that 
up to half of Staphylococcus spp. findings in quarter milk samples originated from sites 
other than the udder. One must also take into account the shortcomings of the reference 
method, such as different NAS exhibiting different growth capacities in BC. 
 
Differences between S. aureus and Staphylococcus spp. were observed in the bacterial 
loads of pathogens detected in the milk samples. In subclinical and clinical cases of 
spontaneous IMI, S. aureus was present usually with low Ct values, indicating high bacterial 
counts in contrast to Staphylococcus spp., which were usually present with high Ct values, 
indicating low bacterial counts (I). These results agree with those of other studies (Table 
15). Higher bacterial counts for S. aureus compared with NAS have been reported also in 
culture-based studies. S. aureus has been reported to be shed in milk in natural IMI cases 
continuously with moderately high colony counts, varying from 8 000 to 338 000 cfu/ml 
(Walker et al., 2013). In our study (I), the mean cfu/ml for S. aureus was 6 000 cfu/ml and 
for CNS 2 000 cfu/ml (unpublished data). Taponen et al. (2007) reported that bacterial 
counts in persistent IMI due to NAS were >1 000 cfu/ml and in transient infections <1 000 
cfu/ml (Taponen et al., 2007). In our experimental study (IV) with high inoculation dose, 
the bacterial counts were 100 – 400 000 cfu/ml. The feature of Staphylococcus spp. usually 
being present in milk samples at low levels makes it even more difficult to evaluate the 








Table 15. Mean Ct values from aseptically collected quarter milk samples for the five most commonly detected 
target pathogens from our studies and other studies undertaken between 2012 and 2017. All samples were 
examined with PathoProofTM Complete-12 or Complete-16 Kit. 





Study I 28.8 32.9 30.6 27.9 29.3 294 
Study II 27.2 33.8 38.4 25.5 30.1 113 
Study III 27.4 31.6 28.2 30.0 29.1 149 
Spittel et al. 20121 BC+ 
PCR+ 
29.4 30.8 34.2 25.5 26 681 




33.9 33.9  
Vakkamäki et al. 20172 31.9 31.5 29.3 27.0 26.6 240067 
1subclinical mastitis samples  
2samples sent from suspected subclinical and clinical mastitis cases 
3total number of analyzed samples in a study 
 
 
The differences between BC and PCR in diagnosing S. aureus and Staphylococcus spp. 
were also evaluated by calculating relative Se and Sp for PCR and testing correlations 
between cfu/ml and gc/ml (I). Se and Sp for S. aureus were 97% and 96% and for 
Staphylococcus spp. 87% and 75%. In comparison, Spittel and Hoedemaker (2012) reported 
Se and Sp values of 79% and 94% for S. aureus and 78% and 68% for Staphylococcus spp. 
Correlation between cfu/ml and gc/ml was higher (0.68) for S. aureus than for 
Staphylococcus spp. (0.47) (I). In our experimental study (IV), where healthy quarters were 
inoculated with high doses of two known CNS species and elimination of bacteria was 
monitored, correlation between cfu/ml and gc/ml was 0.60 for S. epidermidis and 0.55 for 
S. simulans over the whole study period. Correlation between cfu/ml and gc/ml was stronger 
when only one species and strain was present, which is not surprising. Correlations seemed 
to vary notably between quarters and cows. This may be due to the host response: if the 
response is strong, bacteria may not be fit to grow on agar plates, but DNA can remain intact 
for PCR detection. It was reported in Simojoki et al. (2011) that quarters that cleared the 
IMI showed a stronger immune response compared with persistently infected quarters 
(Simojoki et al., 2011). It was also shown that this particular S. simulans strain caused a 
stronger innate immune response than S. epidermidis based on higher proinflammatory 
cytokine levels (Simojoki et al., 2011). Logically, correlations between cfu/ml and gc/ml 
were poor for cows that were cured or yielded several no-growth results in BC, but 
continued to be positive in PCR. Comparisons between cfu/ml and gc/ml may be debated 
because of the basic difference between the units. First, the actual number of bacteria within 
one colony is not known and can vary among species and strains. Secondly, depending on 






expressed in the same genome (Phuektes et al., 2001; Vetrovsky and Baldrian, 2013). For 
example, in the 16S rRNA 5.8 ± 2.8 copies per genome were reported for phyla including 
streptococci, staphylococci, Klebsiella spp. and E. coli (Vetrovsky and Baldrian, 2013). 
Whole genomes for different staphylococci are available, but without knowledge of the 
target sequences in the PCR assays the accuracy of the target sequences cannot be evaluated. 
Presenting cfu and gc in same unit enabled us to present the elimination curves for CNS in 
study IV. 
 
PCR methodology lacks definition for a contaminated sample. Currently all detected 
target pathogens from the sample are reported to the client. In theory, the list may include 
all fifteen different species. Despite the debated hypotheses about mastitis being related to 
dysbiosis of the mammary gland (Addis et al., 2016), the current concept remains that one 
or a maximum of two pathogens cause IMI (Rainard, 2017; Middleton et al., 2017). More 
than two pathogens in the sample indicate contamination (Middleton et al., 2017). Applying 
culture-based standards to molecular-based methods has been questioned (Bexiga et al., 
2011a; Keane et al., 2013) because quantitative data are available. In commercial multiplex 
real-time PCR assays, dominance of a target pathogen can be reported if the target gene of 
some pathogen represents >90 or >99% of all detected DNA in a sample (Thermo Fisher 
Scientific). A sample result with DNA of a dominant major pathogen, accompanied by small 
amounts of two minor pathogens, supported by information of clinical signs typical for the 
major finding, could, in principle, be valid. Such results should, however, be interpreted 
with caution because detection of more than two bacterial species in a milk sample always 
raises concerns about the hygienic quality of the sample, despite the method used.  
 
Milk samples for PCR testing are at least as prone to errors in handling and 
transportation as samples studied with BC. If samples are transported without preservatives 
or are left uncooled, even low amounts of some pathogens such as E. coli could quickly 
outgrow the other pathogens, resulting a falsely high amount of E. coli DNA detected in 
PCR. A carryover may also be a source of contamination. Mahmmod et al. (2017) studied 
a DNA carryover in cows being examined with PCR for S. aureus. Truly IMI negative cows 
represent the biggest risk for false positive S. aureus diagnosis due to the carryover from an 
S. aureus positive cow milked just before her (Mahmmod et al., 2017). Cross-contamination 
in laboratories is also a possibility. Despite the risks of contaminated milk samples for the 
PCR analysis, a high level of hygiene for aseptic quarter milk sampling has been reached in 
published studies (Table 3). According to the knowledge to date, there is no reason why the 
concept of contamination could not be the same in PCR as in culture, when examining result 
sheets for aseptically taken quarter milk samples. All results could still be provided so that 






6.2. The effect of milk sampling technique on multiplex real-time 
PCR results 
Aseptic milk sampling has been the basis for generating reliable microbiological results 
(Middleton et al., 2017), regardless of the diagnostic method. We tested the effect of 
sampling techniques on PCR results in two different studies (II, III). If the teat canal (III) or 
the entire teat (II) was bypassed when taking a milk sample, the proportion of PCR negative 
samples significantly increased. The proportion of multispecies samples (more than two 
species in a sample) was lower when using experimental techniques compared with samples 
taken using conventional aseptic sampling techniques. In addition, the amount of target 
pathogen DNA was higher in samples, which gave positive PCR results despite the sampling 
methods. If target DNA was present only in conventionally taken sample, the DNA amount 
was lower. Our results indicate that despite the careful pre-sampling procedures, target DNA 
originating from outside the mammary gland is often present in conventionally taken 
samples.  
 
The sampling technique also affected the number of species detected in a sample. The 
most striking differences were seen with Staphylococcus spp. in study II, where the 
proportion of positive Staphylococcus spp. detections was over twofold in conventionally 
taken samples compared with needle sampling. A higher proportion of Staphylococcus spp. 
positive findings in conventional samples than in cannula samples was also recorded in 
study III, but the difference was not that notable. In both studies (II, III), the amount of 
detected Staphylococcus spp. DNA was higher in conventional samples than in 
experimentally taken samples, indicating that staphylococcal DNA originated also from 
extramammary sites. Some NAS species are common on teat skin, teat canal and orifice 
(Taponen, 2008). Despite proper cleaning of the teat end, the sterile cannula may be 
contaminated with target DNA from the teat canal at insertion. In study III, a similar 
phenomenon was seen also with yeasts and T. pyogenes/P. indolicus, which were present in 
conventional samples more than twice as often as in cannula samples. This reflects the 
characteristics of yeasts as commonly colonizing the barn environment (Radostits et al., 
2007) and T. pyogenes as an opportunistic pathogen of healthy cows (Madsen et al., 1992).  
 
Our results show that not all pathogen DNA present in milk samples originated from the 
mammary gland, despite the aseptic sampling protocol. Bacteria and DNA material has been 
preserved in ethanol for decades but yields of DNA-products amplified from ethanol 
preserved tissues or bacteria have been low (Barnes et al., 2000; Kilpatrick, 2002).  It is not 
known how the target DNA sequences of PCR mastitis assays behave when subjected to 
small amounts of 70% alcohol or other disinfectants used in teat end scrubbing. Bacteria are 
killed, but DNA may stay intact, as DNA tolerates the multiple washing and dilution 
protocols during DNA extraction before PCR amplification. Use of established pre-milking 
procedures (discarded foremilk strips and teat end scrubbing with 70% alcohol) improved 
the sensitivity of PCR for diagnosing S. aureus (Mahmmod et al., 2013a), but increased the 
odds of the sample containing S. agalactiae DNA (Mahmmod et al., 2014). The mechanical 






disinfection when PCR is used. Some microbes detected with PCR can be considered as 
contaminants, especially when present as small amounts of DNA. If the signs of the cow or 
the degree of udder inflammation do not fit the usual signs caused by the pathogen detected, 
the possibility of contamination should be considered.  
6.3. Cycle threshold (Ct) values and the effect of different cut-offs 
on the PCR results 
The maximum number of cycles in PCR is 40.0 because cycles above 40.0 produces 
nonspecific amplification products of no value (Mullis et al., 1986; Innis et al., 1990). A 
generally accepted norm to separate a true positive signal from contamination is three cycles 
apart from a negative control (Bustin, 2004). This is why the Ct value 37.0 was selected as 
the standard cut-off for a positive detection in PathoProofTM PCR Assays (Koskinen et al., 
2009). Results with Ct values between 37.0 and 40.0 may be of poor reproducibility or 
reliability (Koskinen et al., 2009). An approximately 3.3 cycle difference in Ct values 
translates into a ~10-fold difference in the concentration of the target DNA. 
 
The effects of different Ct cut-offs on the interpretation of PCR results were evaluated 
in study II. The cut-off value had a significant effect on the number of positive samples: the 
lower the cut-off, the fewer positive samples. Usually the results obtained with cut-offs 40.0 
and 37.0 did not differ. This supports the decision to use a Ct cut-off of 37.0, which is 
adequate for the PCR assay, at least when examining quarter milk samples. The results over 
37.0, of questionable reliability, can be neglected. Our results may have been biased due to 
the presence and prevalence of particular species, because in most of the samples the minor 
pathogens Staphylococcus spp. and C. bovis were present (II). Lowering the Ct cut-off value 
affected most samples with Staphylococcus spp. where the number of positive samples 
decreased by over 50% when the Ct value was decreased from 37.0 to 34.0 (II). Also during 
study IV, several samples target-positive with a cut-off of 37.0 were negative with a cut-off 
of 34.0. This effect on the results was seen mostly in samples originating from quarters 
infected with S. epidermidis, but not S. simulans. Decreasing the Ct cut-off value from 37.0 
to 34.0 did not seem to affect the results (positive IMI or not) regarding major pathogens 
such as S. aureus and S. uberis, although we did not have enough data to evaluate these 
findings statistically (II). Low average Ct values for major pathogens, usually under 30.0 
(III), are in agreement with results from a large dataset of Vakkamäki et al. (2017) and 
support this assumption. 
 
The current practice in some laboratories of presenting Ct results as semi-quantitative 
classes (high amount of detected pathogen (+++), moderate amount of targeted pathogen 
(++) or low amount of targeted pathogen (+)) on the report sheet, without providing actual 
Ct values, could be questioned. In study I, fourteen S. aureus positive samples with Ct values 
between 30.1 – and 37.0, considered low according to the manufacturer, resulted in 2 000 
cfu/ml or even 10 000 cfu/ml of S. aureus on agar plates, which clearly indicates S. aureus 






diagnosing S. aureus IMI in cows at drying-off compared with Ct cut-offs 32.0, 34.0 and 
39.0. Mahmmod et al. (2017) stated that during lactation S. aureus should be present in a 
sample with Ct values under 32.0 to indicate a likely IMI. Both of these studies used cow 
composite samples, which are diluted, prone to contamination and where Se is lower than 
in quarter-based samples. We suggest reporting PCR analysis results with actual Ct values, 
instead of semi-quantitative classes. This would improve the interpretation of the results in 
routine practice. Until then, we suggest that at least for S. aureus, in addition to high (+++) 
and moderate (++) amounts of detected DNA, also low amounts (+) should be noted. In case 
of Staphylococcus spp. (NAS), results with low amounts (+) of should be evaluated with 
high criticism. 
6.4. Evaluation of the inflammatory status of the quarter 
Use of NAGase as an indicator of inflammation could be argued against because 
NAGase has been reported to be inferior compared with SCC for identifying IMI-negative 
and IMI-positive quarters (Nyman et al., 2016b). On the other hand, it has been reported as 
an accurate and good measure of udder health by others (Hovinen et al., 2016). NAGase 
testing protocols and units vary, as reviewed by Hovinen et al. (2016), and it may also be 
affected by stage of lactation. In study I, milk SCC records were not available. With 
experience of NAGase testing in our laboratory (Hovinen et al., 2016), NAGase was the 
best choice as an indicator of inflammation for that study. According to milk NAGase 
activities, the majority (84%) of study I samples originated from mastitic quarters.  
 
In studies II-IV milk SCC was used as the indicator for inflammation. In study II, we 
recorded very high SCCs, considering that the most prevalent pathogens detected were 
Staphylococcus spp. and C. bovis. One reason behind this could be particularly pathogenic 
strains present in the study farms, causing strong inflammation and high SCC. Pathogenic 
characteristics of NAS vary among species (Hyvönen et al., 2009; Supre et al., 2011; 
Taponen and Pyörälä, 2009). Another reason for high milk SCCs is that both in healthy and 
subclinically infected quarters, SCC may remain high up to seven hours after milking, with 
the highest levels recorded soon after milking (Olde Riekerink et al., 2007). Our sampling 
in study II was carried out within two hours after morning milking, possibly biasing SCC 
results upwards in the sampled quarters. In study III, sampling took place randomly related 
to the milkings, the veterinarians taking samples at various times of the day during their 
visits. Assessment of the type of mastitis, clinical or subclinical, was based on changes in 
consistency and appearance of the milk and clinical signs of the cow, and not on SCC. 
Regardless of the type of mastitis, the average SCC of both groups was over 2 000 000 
cells/ml, indicating a strong inflammatory reaction. This was expected because a 
veterinarian had been called to examine and treat these cows for mastitis.  
 
In study IV, because the cows were sampled frequently and always prior to milking, 
milk SCC was considered to be a reliable inflammation indicator. Mastitis cure can be 






milk SCC < 100 000) and in clinical mastitis, disappearance of clinical signs. We used the 
bacteriological cure definition because the study period was only two weeks long and the 
decrease of SCC to a normal level after infection may take longer (Pyörälä, 1988). In cured 
quarters, SCC appeared to decrease along with gc/ml. Unfortunately, due to the small 
sample size, we were not able to calculate correlations between SCC and gc/ml. In IMI, the 
neutrophils are the predominant cell type, ingesting and killing bacteria at the infection site 
(Rainard and Riollet, 2006). It may be speculated that at least part of the detected DNA 
could originate from phagocytosed microbial cells. To my knowledge, no studies have 
reported how long DNA remains intact in white blood cells.    
6.5. Limitations of the studies 
As evident in this thesis, milk samples are prone to contamination. Samples in study I 
originated from routine sampling of mastitic cows and were mostly collected by farmers 
under uncontrolled conditions. A recent study with more than 240 000 quarter milk samples 
analyzed with PCR, showed, however, that Finnish farmers are well trained in taking milk 
samples; only 13.4% of the samples included DNA of more than two pathogens (Vakkamäki 
et al., 2017). In study I, the hygienic quality of samples was even better: 8.1% of the samples 
studied with PCR included DNA from more than two pathogens and 12.9% was defined as 
contaminated in BC. In studies II-IV, sampling was carried out by the authors (II, IV) or 
trained veterinarians and veterinary students (III). In study II the sampling procedure was 
always the same: foremilk strips and CMT, then a conventional sample and immediately 
after that the needle sample. In theory, it could be possible that the reduced number of 
species per needle sample could be partly due to the flushing effect of the conventional 
samples taken first, if some milk was removed also from the gland cistern. The same 
sampling order was used also in study III: we took first the conventional samples and then 
cannula samples. In a study by Bexiga et al. (2011b) a similar sampling protocol with 
cannula and conventional sampling was used. They used a random sampling order, which 
had no effect on the results (Bexiga et al., 2011b). 
  
With the sample size in study I, we were able to evaluate the performance of the PCR 
assay in detecting S. aureus and Staphylococcus spp. (NAS). In order to get specific 
information about other species, the study would have benefited from a larger sample size, 
with power calculations based on the knowledge of the prevalence of different pathogens in 
Finland (Myllys et al., 1998; Pitkälä et al., 2004). With our in-depth culture method, where 
each colony from even contaminated agar plates was enumerated and identified, a larger 
sample size was not possible for economic reasons. In studies II and III, the aim was to 
compare the effect of the sampling technique on the PCR results. For general comparisons, 
the sample sizes were adequate, but for pathogen-specific comparisons the studies would 
have needed more samples. The use of invasive methods (II, III) and challenge of healthy 







Latent Class Analyses (LCA) have increasingly been used in estimations of Se and Sp 
in the absence of a gold standard (Dohoo et al., 2010). Those models assume that Se and Sp 
of the diagnostic test should be as good in low prevalence populations as in high prevalence 
populations and tests should be conditionally independent given the disease status (Dohoo 
et al., 2010). The models should be tested in two populations of different disease prevalence. 
Background information on the cows and herds would have increased the validity and 
reproducibility of study I. Creating groups, e.g. according to breed or region, would have 
enabled the use of LCA in determining Se and Sp for PCR, instead of using BC as the 
reference method. This was not possible because the authors were completely uninformed 
about the origin of the samples. Se and Sp for PCR were probably underestimated, because 
BC is not a perfect reference.  
 
In study IV, the inoculum volumes of cultured milk (0.1 ml) were higher and definition 
of a positive result (10 cfu/ml) lower than in routine procedures. This was partly due to the 
original design for the host-response study (Simojoki et al., 2011), but also because we know 
that PCR is a very sensitive test which uses 0.35 ml of milk, and we wanted to make the 
comparison between BC and PCR more fair. If the positive detection limit for CNS had 
been 500 cfu/ml, as for our national recommendation (Honkanen-Buzalski, 1995), the 
agreement between BC and PCR would have decreased. Another technical challenge in 
study IV was that PCR detects Staphylococcus spp. in general and not at species level. 
According to our culture results, no other coagulase-negative staphylococci, nor any other 
species were present in the samples. Sampling protocol was also strict and the surroundings 
controlled, but there is no guarantee that a minimal proportion of genome copies detected 
could have originated from some other NAS species.  
6.6. Use of multiplex real-time PCR in bovine mastitis diagnostics 
– benefits, limitations and future aspects 
Use of multiplex real-time PCR in mastitis diagnostics has several benefits, including 
speed, sensitivity and objectivity. Identification of pathogens according to their genomic 
sequence is more precise than identification based only on phenotypic expression (Gillespie 
and Oliver, 2005). In addition, DNA is a highly stable biological molecule (Pereira et al., 
2008) that can be amplified from milk samples subjected to antimicrobials or preservatives. 
The ability of PCR to detect pathogen DNA from growth-inhibited or non-viable cells may 
be considered an advantage, but is also a disadvantage because the clinical relevance of the 
result remains open.   
 
All DNA or protein sequence analysis identification systems are based on the 
assumption that the same species carry unique DNA or protein sequences, which no other 
species possess (Pereira et al., 2008). Oligo design has focused on highly conserved 
genomic sequences, but variation in genes is constant due to reproduction, migration and 
random genetic drift (Pereira et al., 2008), which is why oligos should be monitored over 






products, the oligo sequences are often protected by patents. Consequently, it is impossible 
to evaluate the test thoroughly or compare it with other tests. Some oligos are designed to 
detect several species of a microbial group and some oligos are unique for single species, 
but still able to amplify different strains of the target species. To differentiate S. aureus from 
the group of other staphylococci, the Ct values for detection must differ by at least three 
cycles. If the design of the oligos is not optimal, no amplification occurs, leading to the 
possibility of false negative results. Furthermore, the more oligos the panel includes, the 
more challenging is optimization of annealing conditions, increasing the chance of errors 
during the cycle (Innis et al., 1990). In addition, there are several kinds of polymerase 
enzymes, some more prone to errors than others. Of the commercial PCR assays, 
PathoProofTM PCR Assays use a hot-start polymerase enzyme, which will activate only 
during the first heating of the first PCR cycle. Information on the type of polymerase 
enzyme in Mastit 4-panels (DNA diagnostic A/S) was not available, but based on the 
worksheet guidelines in which all the pipetting is advised to be performed on cooled ice, 
differences between enzymes may be assumed. Multiplex real-time PCR assays and panels 
available at present for mastitis diagnostics differ in protocols, test volumes and polymerase 
enzymes. Independent high quality studies are needed to compare Se and Sp of the different 
assays. 
 
Finland has excellent BTM SCC figures and high milk quality and Finnish farmers take 
a lot of quarter milk samples – over 150 000 milk samples are examined only with PCR 
each year, covering approximately 80% of all samples. In modern large herds, cow level 
SCC from AMS or DHI samples are used to screen for subclinical mastitis, CMT is 
performed for high SCC cows and quarter-based samples taken if CMT score is 3–5 on a 5-
point scale. Sampling is easy for the farmer: an aseptically taken quarter milk sample is sent 
to the laboratory in the milk truck or via mail with preservatives, and the result is provided 
electronically on the same or the following day. Motivation for such monitoring is a 
prerequisite to maintain good udder health status: information of the most common udder 
pathogens causing IMI on the farm is used in control plans. With the long withdrawal 
periods after mastitis treatments in Finland, farmers are willing to take a milk sample from 
a cow with elevated SCC, hoping that the result does not indicate any need for 
antimicrobials. PathoProofTM Mastitis PCR was launched in 2008 (Thermo Fisher 
Scientific, former Finnzymes, Vantaa, Finland) and quickly adopted. The laboratories of the 
largest dairy company switched from culture to PCR in 2010. Concerns about increasing 
antimicrobial consumption were raised immediately. Since 2010, however, use of 
intramammary antibiotics has decreased (Finnish Medicines Agency Fimea, 2017) and the 
easy logistics has increased use of milk samples in mastitis control. In addition, veterinarians 
are prohibited by law to profit from selling antimicrobial products. A clear disadvantage of 
using only PCR at the national level is that bacterial isolates can no more be collected and 
stored for mastitis surveys and monitoring of resistance. In addition, the only indicator of 
antimicrobial susceptibility is testing for the presence of the staphylococcal beta-lactamase 
gene (blaZ). Technically, including a target sequence, for example for MRSA, into panels 
is not difficult, but for a commercial test such changes are corporate decisions, based on 






problem may create new rules for treatment protocols, which could also require more 
efficient monitoring of antimicrobial resistance of udder pathogens. 
 
Using PCR methods, very high analytical sensitivities have been achieved in spiked 
samples (Graber et al., 2007; Koskinen et al., 2009) as well as in field samples (Cederlöf et 
al., 2012; Keane et al., 2013; Koskinen et al., 2010). This may partly be due to the sample 
volume, which is 350 µl in PathoProofTM and 500 µl in Mastit 4 assays, compared with the 
routine 10 µl for BC. We work in a barn environment full of bacteria, where aseptic milk 
sampling is a challenge, not to mention samples taken with automatic devices. In these 
conditions, excessive analytical sensitivity for diagnostic purposes may potentially turn into 
a disadvantage. Nyman et al. (2016a) concluded that using non-aseptically collected milk 
samples will increase Se, while Sp is kept at a similar level or lower, compared with BC of 
aseptically collected milk samples. Mahmmod et al. (2017) concluded that the true status of 
a cow-based composite milk result studied with PCR, regarding S. aureus (Ct values 
between 32.0 and 37.0), remains “uncertain”. Too high Se in diagnosing mastitis may be 
problematic, especially for pathogens present at low levels and being common inhabitants 
of udder skin and the barn environment. Interpretation of composite samples is even more 
difficult than quarter-based samples. Screening for major and easily spreading pathogens 
like M. bovis from cow composite samples within a herd is economically sensible, but the 
possibility of carryover when using automatic sampling devices should be taken into 
account. Mahmmod et al. (2017) suggested that in screening DHI samples with PCR, 
milking order and the Ct value of the preceding cow should be included in the diagnostic 
process. BTM samples include a high number of different target pathogens (Katholm et al., 
2012), thus their diagnostic value is in country-level screening of rare, highly contagious 
major pathogens, like M. bovis in the Nordic countries. A positive DNA detection from 
BTM samples may reveal a need for cow level screening to find positive carrier animals. 
 
Clinical relevance is the key point in interpreting PCR results. Bacteriological results 
must be combined with all available information, including history and clinical signs of the 
cow, palpatory findings of the udder, changes in milk and SCC. If the signs do not support 
the microbiological result, it could be questioned. In clear atypical cases, the possibility of 
contamination or presence of a causative pathogen not included in the test panel should be 
considered and a new milk sample submitted for conventional culturing. For example, a 
cow with severe signs, but with a milk sample result positive only for C. bovis with a low 
amount of DNA, should automatically raise a question in the clinician’s mind as to whether 
the cause of mastitis might be some other pathogen not included in the test panel. Future 
research in PCR diagnostics should focus on defining true IMI. This could be done by 
testing and monitoring clinically healthy quarters, as well as those with subclinical or 
clinical mastitis, with PCR assays and comparing SCC or other indicators of inflammation 
with PCR results. Such studies require large datasets to obtain also pathogen-specific 
information. The relevance of the blaZ gene targeted in milk samples should also be looked 






7 Conclusions  
This research aimed at improving the interpretation of multiplex real-time PCR results 
obtained from bovine mastitis cases. Conclusions based on this thesis are: 
• Multiplex real-time PCR assay is a reliable tool for diagnosing S. aureus IMI from 
aseptically-taken quarter milk samples when compared with conventional culture.  
• Microbes not related to IMI appear in microbiological results for milk samples tested 
with PCR despite using an aseptic sampling method. Environmental and minor 
pathogens detected with low amounts of DNA can be considered to originate mostly 
from extramammary sites. 
• Half of the Staphylococcus spp., i.e. non-aureus staphylococci, in the milk samples may 
originate from the teat canal, teat skin or teat orifice. In PCR these are usually present 
with high Ct values (>34.0), indicating low numbers of bacteria. In case of 
Staphylococcus spp. (NAS), results with low amounts of detected DNA should be 
evaluated with high criticism. 
• Detection of more than two target species, especially bacteria of environmental origin 
and with small amounts of detected DNA, raises concerns about the hygienic quality of 
the sample. In cases where the predominant bacteria cannot clearly be identified, or the 
sample includes more than two species, the sample should be considered contaminated.  
• Bacteriological cure appears to occur faster if the sample is examined with BC compared 
with PCR. These samples include intact target DNA from viable, damaged or dead 
bacterial cells. Thus, sampling during the acute phase of mastitis increases the 
probability of the PCR result originating from viable cells. Based on this study we 
recommend waiting at least two to three weeks after the onset of mastitis or possible 
antimicrobial treatment, or until the quarter milk SCC has decreased to a normal level, 
before taking milk samples for PCR analysis to assess a bacterial cure. 
• Major pathogens like S. aureus are present in samples from suspected IMI cases with 
lower average Ct values than minor pathogens like Staphylococcus spp. We recommend 
that actual Ct values would be presented in PCR analysis results instead of current 
estimates of high, moderate and low levels of DNA because these estimates may differ 
among target species.  
• Mastitis diagnosis, especially when using PCR, should include all available information 
on the history and clinical signs of the cow, palpatory changes in the udder, changes in 
the milk appearance, and indicators of inflammation, including milk SCC. This 
information should be combined with the microbiological diagnosis. In atypical cases, 
the possibility of contamination or presence of a causative pathogen not included in the 
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